Total Synthesis of Candicanoside A, a Potent Antitumor Saponin Bearing a Rearranged Steroidal Side Chain
|
|
- 杏 鲁
- 5 years ago
- Views:
Transcription
1 Total Synthesis of Lobatoside E, a Potent Antitumor Cyclic Triterpene Saponin Chunsheng Zhu, Pingping Tang, and Biao Yu* State Key Laboratory of Bio-organic and Natural Products Chemistry, Shanghai Institute of rganic Chemistry, Chinese Academy of Sciences, Shanghai , China byu@mail.sioc.ac.cn Supporting Information Experimental details, characterization data, and NMR spectra for new compounds.
2 BnBr, K 2 C 3,Bu 4 NBr C 2 Cl 2 / 2, 50 o C,94% Bn 8 S1 To a suspension of oleanolic acid 8 (4.56 g, 10 mmol) in C 2 Cl 2 (150 ml) were added a solution of K 2 C 3 (2.76 g, 20 mmol) in water (50 ml), Bu 4 NBr (2.58g, 8 mmol) and BnBr (1.8 ml, 15 mmol). The mixture was stirred at 50 o C for 6 h and was quenched by addition of aqueous Cl (1 N), and followed by dilution with C 2 Cl 2. The organic layerl was separated, washed ( 2 and then brine) and dried over Na 2 S 4. Concentration in vacuo and purification by silica gel flash column chromatography (petroleum ether/etac: 8/1) furnished S1 (5.11 g, 94%) as a white solid: 1 NMR (300 Mz, CDCl 3 ) δ 7.34 (m, 5), 5.30 (s-like, 1), 5.07 (AB, 2), 3.21 (dd, J = 4.8, 9.9 z, 1), 2.91 (dd, J = 3.9, 13.2 z, 1), 1.13, 0.98, 0.92, 0.90, 0.88, 0.78, 0.61 (s, each 3). Bn Jones reagent, acetone 0 o Ctort,92% Bn S1 S2 Benzyl oleanolate S1 (14.40 g, mmol) was dissolved in acetone (250 ml), and Jones reagent (14 ml) was added dropwise at 0 o C. After stirring at 0 o C for 30 min, the reaction mixture was quenched by addition of i-pr, followed by concentration in vacuo to remove acetone. The residue was dissolved in C 2 Cl 2, washed ( 2 and then brine), and dried over Na 2 S 4. Concentration in vacuo and purification by silica gel flash column chromatography (petroleum ether/c 2 Cl 2 : 1/1 to 1/2) furnished S2 (13.28 g, 92%) as a white solid: [α] 25 D = 76.2 (c 1.12, CCl 3 ); 1 NMR (300 Mz, CDCl 3 ) δ 7.34 (m, 5), 5.29 (s-like, 1), 5.08 (AB, 2), 2.91 (dd, J = 4.5, 14.1 z, 1), 2.54 (ddd, J = 6.9, 10.5, 15.6 z, 1), 2.35 (ddd, J = 3.3, 6.6, 15.6 z, 1), 1.13, 1.08, 1.04, 1.01, 0.92, 0.90, 0.65 (s, each 3); ESI-MS m/z 545 [M+] +, 583 [M+K] +. Anal. Calcd for C : C, 81.57;, Found: C, 81.44;, S1
3 Bn 2 N Cl, NaAc, Me/C 2 Cl 2, reflux, 95% Bn N S2 9 Compound S2 (92 mg, 0.17 mmol) was dissolved in Me/C 2 Cl 2 (6 ml/3 ml), and N 2 Cl (18 mg, 0.25 mmol) and NaAc (42 mg, 0.51 mmol) was added at rt. After stirring overnight at reflux, the reaction mixture was diluted by addition of brine, then extracted with C 2 Cl 2. The extract was dried over Na 2 S 4, followed by filtration, concentration in vacuo, and purification by silica gel flash column chromatography (petroleum ether/c 2 Cl 2 : 1/1 to 1/2) to give 9 (96 mg, 95%) as a white foam: [α] 25 D = 17.7 (c 1.12, CCl 3 ); 1 NMR (300 Mz, CDCl 3 ) δ 7.33 (m, 5), 5.29 (s, 1), 5.07 (AB, 2), 3.07 (ddd, J = 3.0, 5.1, 15.3 z, 1), 2.90 (dd, J = 3.6, 13.8 z, 1), 2.14 (m, 1), 1.14, 1.10, 1.04, 0.99, 0.91, 0.89, 0.63 (s, each 3); 13 C NMR (75 Mz, CDCl 3 ) δ 177.5, 166.9, 143.7, 136.5, 128.4, 128.3, 128.2, 128.0, 127.9, 122.4, 66.0, 55.9, 47.2, 46.8, 45.8, 41.8, 41.7, 41.5, 40.4, 39.4, 38.5, 37.1, 33.9, 33.1, 32.5, 32.4, 30.7, 27.6, 27.2, 25.8, 23.7, 23.5, 23.3, 23.1, 19.1, 17.1, 16.9, 14.9; RMS (ESI) m/z calcd for C N [M+] +, found N 9 Bn 1) Na 2 PdCl 4,NaAc,Ac,rt 2) Ac 2, Et 3 N, DMAP,C 2 Cl 2,rt 3) Py, TF; Pb(Ac) 4,Ac, -78 o Ac Ctort;NaB 4, aq.na, rt, 72% N To a solution of benzyl 3-hydroxyiminoolean-12-en-28-oate 9 (1.00 g, 1.67 mmol) in Ac (90 ml) were added NaAc (150 mg, 1.83 mmol) and Na 2 PdCl 4 (562 mg, 1.87 mmol). The solution was stirred for 72 h at rt, and ice water (150 ml) was added to give a yellow precipitate. The palladium complex was filtered and dried in vacuo for 24 h. To a solution of this yellow solid in dry C 2 Cl 2 (15 ml) were added DMAP (19 mg, 0.15 mmol), Et 3 N (0.33 ml, 2.36 mmol), and Ac 2 (0.21 ml, 2.21 mmol). The reaction mixture was stirred at rt for 45 min, washed with water and brine, dried over anhydrous Na 2 S 4, filtered, and evaporated at reduced pressure. The crude product was dissolved in dry TF (60 ml), and pyridine (0.12 ml, 1.41 mmol) was added. The reaction mixture Ac 10 Bn S2
4 was stirred for 15 min at rt and cooled at -78 o C, and a solution of Pb(Ac) 4 (708 mg, 1.60 mmol) in Ac (24 ml) was added. and the stirring continued at rt for 30 h. To remove the remaining Pd salts, a solution of NaB 4 (58 mg, 1.52 mmol) in 1 N Na solution (22 ml) was added to the reaction mixture. The mixture was stirred for 15 min and filtered. The filtrate was diluted with C 2 Cl 2, which was washed with saturated aqueous NaC 3 solution, dried over Na 2 S 4, filtered, and evaporated in vacuo to give a white solid. The solid was purified by silica gel flash column chromatography (petroleum ether/etac: 6/1 to petroleum ether/c 2 Cl 2 : 1/2) to give 10 (791 mg, 72%) as a white foam: [α] 25 D = 75.4 (c 1.00, CCl 3 ); 1 NMR (300 Mz, CDCl 3 ) δ 7.33 (m, 5), 5.30 (s-like, 1), 5.07 (AB, 2), 4.16 (AB, 2), 2.91 (dd, J = 3.3, 13.5 z, 1), 2.76 (ddd, J = 3.3, 6.6, 16.2 z, 1), 2.50 (m, 1), 2.17, 2.05, 1.16, 1.11, 0.95, 0.92, 0.89, 0.63 (s, each 3); 13 C NMR (75 Mz, CDCl 3 ) δ 177.4, 170.9, 170.6, 169.7, 143.8, 136.4, 128.4, 128.0, 127.9, 122.2, 68.1, 68.0, 66.0, 48.5, 46.8, 46.7, 45.8, 43.9, 41.8, 41.5, 39.2, 37.0, 36.5, 33.9, 33.1, 32.3, 32.0, 30.7, 27.6, 25.7, 25.6, 23.6, 23.5, 23.1, 21.0, 20.3, 20.0, 19.4, 19.3, 16.8, 15.3; RMS (MALDI) m/z calcd for C N 6 Na [M+Na] +, found Bn Na 2 C 3,Me,99% Bn Ac N N Ac 10 S3 A solution of 10 (595 mg, 0.90 mmol) and Na 2 C 3 (478 mg, 4.51 mmol) in Me (90 ml) was stirred at rt for 22 h. After removing Me in vacuo, the resulting colorless solid was dissolved in Et 2. The organic layer was washed with 1 N aqueous Cl solution, saturated aqueous NaC 3 solution and brine, dried over Na 2 S 4, filtered, and evaporated in vacuo to give a solid. The solid was purified by silica gel flash column chromatography (petroleum ether/etac: 4/1) to give S3 (512 mg, 99%) as a white foam: [α] 26 D = 25.1 (c 1.20, CCl 3 ); 1 NMR (300 Mz, CDCl 3 ) δ 7.34 (m, 5), 5.29 (s-like, 1), 5.07 (AB, 2), 3.55 (AB, 2), 3.32 (br, 1), 3.11 (ddd, J = 2.4, 4.8, 18.3 z, 1), 2.90 (dd, J = 4.2, 10.8 z, 1), 1.11 (s, 3), 1.02 (s, 6), 0.91, 0.89, 0.64 (s, each 3); 13 C NMR (75 Mz, CDCl 3 ) δ 177.4, 166.1, 143.7, 136.3, 128.3, 127.9, 127.8, 122.2, 67.7, S3
5 65.9, 49.8, 46.9, 46.7, 45.7, 44.6, 41.7, 41.4, 39.2, 37.8, 36.7, 33.8, 33.0, 32.3, 32.2, 30.6, 27.5, 25.8, 23.6, 23.4, 23.0, 18.8, 18.4, 17.3, 16.9, 15.0; RMS (MALDI) m/z calcd for C N [M+] +, found Bn TiCl 3,N 4 Ac, TF/ 2, 95% Bn N S3 S4 To a solution of S3 (113 mg, 0.20 mmol) in TF/ 2 (7 ml/7 ml) were added N 4 Ac (189 mg, 2.45 mmol) and a buffered solution of TiCl 3 (0.42 ml of aqueous Cl solution containing 15% TiCl 3, 0.49 mmol). The mixture was stirred at rt for 10 h, and was then extracted with Et 2. The extract was washed with saturated aqueous NaC 3 solution and brine, dried over Na 2 S 4, filtered, and evaporated in vacuo to give a solid. The solid was purified by silica gel flash column chromatography (petroleum ether/etac: 4/1) to give S4 (104 mg, 95%) as a white foam: [α] 26 D = 61.8 (c 1.00, CCl 3 ); 1 NMR (300 Mz, CDCl 3 ) δ 7.33 (m, 5), 5.30 (s-like, 1), 5.07 (AB, 2), 3.64 (d, J = 12.0 z, 1), 3.41 (d, J = 11.7 z, 1), 2.91 (dd, J = 3.6, 13.2 z, 1), 2.62 (m, 1), 2.42 (br, 1), 2.26 (m, 1), 1.94 (m, 4), 1.13, 1.11, 1.02, 0.92, 0.90, 0.67 (s, each 3); ESI-MS m/z 561 [M+] +. Anal. Calcd for C : C, 77.99;, Found: C, 78.11;, Bn BnC(N)CCl 3,Tf, dioxane, 0 o C,91% Bn S4 11 Bn To the solution of S4 (2.00 g, 3.57 mmol) and BnC(N)CCl 3 (2.00 g, 7.97 mmol) in dioxane (30 ml, dried over 4Å MS) at 0 o C, was added Tf (0.16 ml, 1.80 mmol) dropwise. After stirring for at 0 o C for 1 h, the reaction mixture was quenched by addition of saturated aqueous NaC 3 solution, diluted with brine, and extracted with C 2 Cl 2. The extract was dried over Na 2 S 4, followed by filtration, concentration in vacuo, and S4
6 purification by silica gel flash column chromatography (petroleum ether/etac: 20/1) to give 11 (2.10 g, 91%) as a colorless oil: [α] 24 D = 74.3 (c 1.05, CCl 3 ); 1 NMR (300 Mz, CDCl 3 ) δ 7.32 (m, 10), 5.33 (s-like, 1), 5.08 (AB, 2), 4.55 (d, J = 12.3 z, 1), 4.37 (d, J = 12.3 z, 1), 3.52 (d, J = 8.7 z, 1), 3.21 (d, J = 8.7 z, 1), 2.92 (dd, J = 4.2, 13.8 z, 1), 2.44 (m, 1), 1.17, 0.95, 0.93 (s, each 3), 0.91 (s, 6), 0.66 (s, 3); 13 C NMR (125 Mz, CDCl 3 ) δ 216.3, 177.3, 143.6, 138.5, 136.4, 128.3, 128.2, 127.9, 127.8, 127.3, 127.2, 122.4, 75.1, 73.0, 65.9, 51.1, 47.1, 46.7, 46.1, 45.8, 41.8, 41.5, 39.2, 37.2, 36.2, 35.5, 33.8, 33.0, 32.3, 31.9, 30.6, 27.6, 25.7, 23.6, 23.4, 23.0, 19.5, 17.8, 16.8, 15.0; RMS (MALDI) m/z calcd for C Na [M+Na] +, found Bn 11 Bn 1) LDA, TF, -78 o C,TMSCl, 89% 2) mcpba, C 2 Cl 2,-5to-10 o C 3) TBAF, TF, -5 to -10 o C,94% To TF (10 ml) under stirring at -78 o C, were added i Pr 2 N (3.70 ml, 38 mmol) and n BuLi (20 ml, 1.6 M in hexanes). The stirring continued for 30 min, a solution of 11 (2.10 g, 3.2 mmol) in TF (30 ml) was then added dropwise. After another 1 h, TMSCl (8.20 ml, 64 mmol) was added. After stirring at -78 o C for 1.5 h, the reaction mixture was quenched by addition of saturated aqueous NaC 3 solution, diluted with brine, and extracted with C 2 Cl 2. The extract was dried over Na 2 S 4, followed by filtration, concentration in vacuo, and purification by silica gel flash column chromatography (petroleum ether/c 2 Cl 2 : 3.5/1) to give the silyl enol ether M1 (2.02 g, 89%) as a white foam: 1 NMR (300 Mz, CDCl 3 ) δ 7.26 (m, 7), 7.10 (m, 3), 5.52 (s-like, 1), 5.28 (brs, 1), 4.72 (d-like, J = 4.8 z, 1), 4.61 (d, J = 12.6 z, 1), 4.39 (d, J = 13.2 z, 1), 3.29 (d, J = 8.4 z, 1), 3.05 (d, J = 9.0 z, 1), 2.92 (dd, J = 3.0, 14.4 z, 1), 1.13 (s, 2), 0.95 (s, 1), 0.90 (s, 6), 0.85 (s, 3), 0.71 (s, 3), 0.42 (s, 2), 0.35 (s, 1), 0.16 (s, 9), 0.01 (s, 9); 13 C NMR (75 Mz, CDCl 3 ) δ 177.1, 152.4, 143.5, 143.2, 140.1, 140.0, 139.2, 128.1, 128.0, 127.9, 127.4, 127.1, 126.0, 125.9, 125.8, 123.0, 101.6, 73.0, 72.6, 71.0, 70.9, 46.8, 46.0, 45.9, 44.9, 42.3, 41.8, 41.7, 41.6, 39.4, 39.1, 39.0, 35.8, 34.0, 33.1, 32.6, 31.9, 30.7, 29.7, 27.6, 25.7, 23.5, 23.3, 23.2, 19.2, 16.8, 16.4, 15.8, 15.7, Bn 12 Bn S5
7 0.5, -3.7, To a solution of the silyl enol ether M1 (2.40 g, 3.02 mmol) in C 2 Cl 2 (31 ml) under stirring at -7 o C, was added mcpba (1.11 g containing of 70% of mcpba, 4.53 mmol), followed by quenching with 10% aqueous Na 2 S 2 3 solution after 15 min. The resulting mixture was diluted with brine and extracted with C 2 Cl 2. The extract was dried over Na 2 S 4 and followed concentrated in vacuo. The crude product was dissolved in TF (31 ml) at -7 o C, then TBAF (7.60 ml, 1 M) was added. After stirring at -7 o C for 45 min, the reaction mixture was quenched by addition of saturated aqueous NaC 3 solution, and was then diluted with brine, and extracted with C 2 Cl 2. The extract was dried over Na 2 S 4, filtered, and concentrated in vacuo. Purification of the residue by silica gel column chromatography (petroleum ether/c 2 Cl 2 : 10/1 to 8/1) gave 12 (1.85 g, 94%) as a white foam: [α] 25 D = 48.6 (c 1.12, CCl 3 ); 1 NMR (300 Mz, CDCl 3 ) δ 7.32 (m, 10), 5.31 (s, 1), 5.08 (AB, 2), 4.65 (d, J = 12.3 z, 1), 4.46 (br, 1), 4.44 (d, J = 12.0 z, 1), 3.81 (d, J = 9.3 z, 1), 3.59 (d, J = 2.1 z, 1), 3.17 (d, J = 9.0 z, 1), 2.92 (dd, J = 3.9, 13.8 z, 1), 2.37 (dd, J = 6.3, 12.0 z, 1), 1.22, 1.14, 0.95, 0.93, 0.91, 0.65 (s, each 3); 13 C NMR (75 Mz, CDCl 3 ) δ 213.9, 177.1, 143.6, 138.3, 136.2, 128.2, 128.0, 127.8, 127.7, 127.3, 127.2, 121.9, 72.8, 71.1, 69.2, 65.7, 51.2, 48.6, 47.5, 46.9, 46.4, 45.5, 41.6, 41.1, 39.1, 36.8, 33.6, 32.9, 32.1, 31.7, 30.5, 29.5, 27.3, 25.6, 23.4, 23.3, 22.8, 18.4, 17.5, 16.9, 16.2; RMS (MALDI) m/z calcd for C Na [M+Na] +, found Bn 4N Cl in Me, reflux, 87% Bn Bn Bn To a solution of 12 (1.85 g, 2.84 mmol) in Me (30 ml), was added Cl (1 ml, 12 M). The mixture was stirred at reflux for 20 min, followed by quenching with saturated aqueous NaC 3 solution. The mixture was diluted with brine and extracted with C 2 Cl 2. The extract was dried over Na 2 S 4, filtered, and concentrated in vacuo to give a residue, which was purified by silica gel column chromatography (petroleum ether/etac: 13/1) to give 13 (1.60 g, 87%) as a white foam: [α] 25 D = 76.3 (c 1.24, S6
8 CCl 3 ); 1 NMR (300 Mz, CDCl 3 ) δ 7.32 (m, 10), 5.30 (s, 1), 5.07 (AB, 2), 4.65 (d, J = 11.7 z, 1), 4.46 (m, 2), 3.42 (d, J = 4.2 z, 1), 3.33 (d, J = 9.3 z, 1), 3.26 (d, J = 9.3 z, 1), 2.92 (dd, J = 2.7, 12.9 z, 1), 2.44 (d, J = 12.0 z, 1), 1.19, 0.93, 0.91, 0.84, 0.57, 0.55 (s, each 3); 13 C NMR (75 Mz, CDCl 3 ) δ 212.0, 177.3, 143.8, 138.5, 136.3, 128.3, 128.2, 127.9, 127.8, 127.5, 127.4, 121.7, 72.8, 72.3, 65.9, 52.8, 48.7, 47.3, 46.6, 46.1, 45.7, 43.2, 41.7, 41.3, 39.6, 33.7, 33.0, 32.2, 31.8, 30.6, 27.5, 25.7, 23.5, 23.2, 22.9, 18.0, 16.7, 16.4, 13.2; RMS (MALDI) m/z calcd for C Na [M+Na] +, found Bn Ac 2, DMAP, pyridine, 95% Bn Ac 13 S5 Bn Bn To a solution of 13 (115 mg, 0.18 mmol) in pyridine (2 ml) under stirring at rt, were added DMAP (4 mg, 0.04 mmol) and Ac 2 (33 μl, 0.35 mmol). After stirring for 19 h, the solution was diluted with EtAc and washed with 1 N aqueous Cl solution and brine. The organic layer was dried over Na 2 S 4, filtered, and evaporated in vacuo to give a solid, which was purified by silica gel column chromatography (petroleum ether/etac: 12/1) to give S5 (119 mg, 95%) as a white foam: [α] 26 D = (c 1.24, CCl 3 ); 1 NMR (300 Mz, CDCl 3 ) δ 7.33 (m, 10), 5.43 (s, 1), 5.30 (s, 1), 5.07 (AB, 2), 5.50 (AB, 2), 3.21 (d, J = 9.9 z, 1), 3.01 (d, J = 9.6 z, 1), 2.92 (dd, J = 4.2, 14.1 z, 1), 2.38 (d, J = 12.0 z, 1), 2.05, 1.19, 0.93, 0.92, 0.87, 0.69, 0.57 (s, each 3); 13 C NMR (75 Mz, CDCl 3 ) δ 204.9, 177.1, 169.8, 143.6, 138.0, 136.2, 128.2, 128.1, 127.8, 127.7, 127.6, 127.5, 121.7, 78.6, 72.6, 71.0, 65.7, 53.5, 47.1, 46.7, 46.5, 45.6, 42.5, 41.6, 41.2, 39.5, 33.7, 32.9, 32.1, 31.7, 30.5, 27.4, 25.7, 23.5, 23.2, 22.8, 20.4, 17.9, 16.4, 16.3, 13.9; RMS (MALDI) m/z calcd for C Na [M+Na] +, found Bn NaB 4,Me/C 2 Cl 2, -10 o C, 95% Bn Ac Ac Bn S5 Bn 14 S7
9 To a solution of S5 (1.51 g, 2.13 mmol) in C 2 Cl 2 /Me (20 ml/20 ml) under stirring at -10 o C, was added NaB 4 (807 mg, mmol). The stirring continued for 30 min, the solution was quenched by addition of saturated aqueous N 4 Cl solution, and then diluted with brine and extracted with C 2 Cl 2. The extract was dried over Na 2 S 4, filtered, and concentrated in vacuo. The residue was purified by silica gel column chromatography (petroleum ether/etac: 5.2/1) to give 14 (1.44 g, 95%) as a white foam: [α] 24 D = 79.3 (c 1.30, CCl 3 ); 1 NMR (300 Mz, CDCl 3 ) δ 7.33 (m, 10), 5.30 (s-like, 1), 5.10 (d, J = 3.6 z, 1), 5.07 (AB, 2), 4.44 (AB, 2), 4.22 (d, J = 3.6 z, 1), 3.06 (d, J = 9.6 z, 1), 2.91 (br, 1), 2.89 (d, J = 9.6 z, 1), 2.04, 1.25, 1.13, 0.96, 0.92, 0.91, 0.61 (s, each 3); 13 C NMR (75 Mz, CDCl 3 ) δ 177.1, 170.0, 143.3, 138.3, 136.0, 128.1, 127.9, 127.7, 127.6, 127.3, 127.1, 122.3, 75.1, 72.5, 72.3, 68.7, 65.6, 47.6, 46.8, 46.4, 45.4, 43.0, 41.5, 41.1, 40.5, 39.0, 36.2, 33.5, 32.9, 32.1, 32.0, 27.2, 25.6, 23.4, 23.2, 22.7, 20.7, 17.2, 16.6, 14.3; RMS (MALDI) m/z calcd for C Na [M+Na] +, found Bn BnC(N)CCl 3,Tf, dioxane, 0 o C to rt, 100% Bn Bn Ac Ac 14 S6 Bn Bn To a mixture of 14 (142 mg, 0.20 mmol), BnC(N)CCl 3 (150 mg, 0.60 mmol), and 4 Å MS, was added dioxane (2 ml). The mixture was stirred for 1 h at 0 o C, then Tf (6 μl, 0.06mmol) was added dropwise. After stirring for 2 h, the solution was quenched by addition of saturated aqueous NaC 3 solution, and was then diluted with brine and extracted with C 2 Cl 2. The extract was dried over Na 2 S 4, followed by filtration, and concentration in vacuo. The residue was purified by silica gel column chromatography (petroleum ether/etac: 19/1) to give S6 (159 mg, 100%) as a white foam: [α] 26 D = 95.8 (c 1.19, CCl 3 ); 1 NMR (300 Mz, CDCl 3 ) δ 7.26 (m, 15), 5.27 (s, 1), 5.03 (AB, 2), 4.99 (d, J = 3.6 z, 1), 4.53 (d, J = 12.3 z, 1), 4.40, (s, 2), 4.34 (d, J = 11.7 z, 1), 3.97 (d, J = 3.6 z, 1), 3.04 (d, J = 9.3 z, 1), 2.94 (d, J = 9.9 z, 1), 2.87 (dd, J = 3.9, 14.1 z, 1), 2.07 (dd, J = 3.0, 14.4 z, 1), 1.92, 1.18, 1.10, 0.94, 0.89, 0.87, 0.58 (s, each 3); 13 C NMR (125 Mz, CDCl 3 ) δ 177.4, 170.6, 143.7, 139.1, 138.6, S8
10 136.3, 128.3, 128.2, 128.1, 127.9, 127.8, 127.5, 127.3, 127.1, 126.9, 122.4, 76.4, 74.9, 72.7, 72.4, 71.7, 65.9, 47.8, 47.1, 46.7, 45.7, 41.8, 41.3, 40.9, 40.0, 39.3, 36.7, 33.8, 33.0, 32.3, 32.2, 30.6, 27.4, 25.9, 23.6, 23.5, 23.0, 21.0, 17.5, 16.9, 16.2, 14.3; RMS (MALDI) m/z calcd for C Na [M+Na] +, found Bn Bn NaMe, Me/C 2 Cl 2, reflux, 93% Bn Bn Ac Bn S6 Bn S7 NaMe (cat.) was added to a solution of S6 (903 mg, 1.13 mmol) in Me/C 2 Cl 2 (10 ml / 10 ml), and was stirred for 49 h at reflux. The mixture was diluted with C 2 Cl 2, washed by 1 N aqueous Cl solution and brine, and dried over Na 2 S 4. Filtration, concentration in vacuo, and purification by silica gel column chromatography (petroleum ether/etac: 13/1) provided S7 (796 mg, 93%) as a white foam: [α] 26 D = 65.3 (c 1.07, CCl 3 ); 1 NMR (300 Mz, CDCl 3 ) δ 7.25 (m, 15), 5.23 (s, 1), 4.99 (AB, 2), 4.68 (d, J = 11.1 z, 1), 4.52 (d, J = 11.7 z, 1), 4.35 (d, J = 12.3 z, 1), 4.22 (d, J = 11.4 z, 1), 4.82 (d, J = 4.2 z, 1), 3.69 (dd, J = 5.1, 10.2 z, 1), 3.34 (d, J = 9.0 z, 1), 3.02 (d, J = 9.6 z, 1), 2.84 (dd, J = 4.2, 12.9 z, 1), 2.60 (d, J = 9.6 z, 1), 2.19 (dd, J = 2.1, 15.0 z, 1), 1.90 (m, 3), 1.11, 1.08, 0.86, 0.84, 0.77, 0.55 (s, each 3); 13 C NMR (75 Mz, CDCl 3 ) δ 177.3, 143.7, 138.9, 138.3, 136.3, 128.8, 128.4, 128.3, 128.1, 127.9, 127.8, 127.4, 127.3, 127.2, 127.1, 122.3, 79.2, 73.5, 72.8, 71.6, 71.2, 65.8, 47.8, 46.8, 46.6, 45.7, 41.9, 41.8, 41.3, 39.3, 39.0, 36.5, 33.8, 33.0, 32.3, 32.2, 30.6, 29.6, 27.4, 25.8, 23.6, 23.5, 22.9, 17.5, 16.8, 16.0, 13.6; RMS (MALDI) m/z calcd for C Na [M+Na] +, found Bn Bn LiI, collidine, reflux, 98% Bn S7 2 Bn Bn LiI (2.24 g, mmol) was added to a solution of S7 (1.26 g, 1.66 mmol) in collidine (17 ml). The mixture was stirred for 11 h at reflux, and was then diluted with S9
11 C 2 Cl 2, washed by 1 N aqueous Cl solution and brine, and dried over Na 2 S 4. Filtration, concentration in vacuo, and purification by silica gel column chromatography (petroleum ether/etac: 6/1) gave 2 (1.09 g, 98%) as a white foam: [α] 25 D = 83.1 (c 1.01, CCl 3 ); 1 NMR (300 Mz, CDCl 3 ) δ 7.28 (m, 10 ), 5.29 (s, 1), 4.73 (d, J = 11.4 z, 1), 4.59 (d, J = 12.3 z, 1), 4.41 (d, J = 12.3 z, 1), 4.28 (d, J = 11.4 z, 1), 3.88 (s, 1), 3.76 (d, J = 3.9 z, 1), 3.38 (d, J = 9.3 z, 1), 3.05 (d, J = 9.0 z, 1), 2.83 (dd, J = 2.4, 12.6 z, 1), 2.25 (d, J = 13.8 z, 1), 1.99 (m, 3), 1.19, 1.14, 0.93, 0.91, 0.76, 0.74 (s, each 3); 13 C NMR (75 Mz, CDCl 3 ) δ 184.4, 143.7, 138.9, 138.3, 128.3, 128.1, 127.4, 127.3, 127.2, 122.4, 79.2, 73.5, 72.8, 71.7, 71.3, 47.8, 46.8, 46.4, 45.7, 41.8, 41.6, 40.8, 39.2, 38.9, 36.6, 33.7, 33.0, 32.4, 32.0, 30.6, 27.5, 26.0, 23.5, 23.5, 22.7, 17.4, 17.2, 16.0, 13.5; RMS (MALDI) m/z calcd for C Na [M+Na] +, found L-Arabinose Bn Bn 7 steps, 46%, ref 1 TMSBr, C 2 Cl 2,rt Bn Ac Bn Ac Ac Br S8 3 TMSBr (0.38 ml, 2.80 mmol) was added to a stirred solution of S8 1 (465 mg, 1.12 mmol) in C 2 Cl 2 (12 ml) at 0 o C. After stirring for 10 h at rt, the solution was evaporated in vacuo to give a light-yellow syrup, which was diluted with EtAc and evaporated (for 3 times to remove the remaining TMSBr). The crude product 3 was used for the next step without further purification. D-Galactose 6 steps, 45% Bn Bn TBDPS PhI(Bz) 2,BF 3 Et 2, Bn TBDPS -45to-25 o C,79% Bn Bz Bz S9 S10 BF 3 Et 2 (0.12 ml, 0.92 mmol) was added to a solution of S9 2 (2.59 g, 4.58 mmol) and PhI(Bz) 2 (2.45 g, 5.49 mmol) in C 2 Cl 2 at -45 o C. After stirring for 30 min, the mixture was warmed up to -25 o C and stirred for 30 min. The solution was cooled to -45 o C and Et 3 N (3.2 ml, mmol) was added. The solution was diluted with C 2 Cl 2, washed by brine, and dried over Na 2 S 4. Filtration, concentration in vacuo, and purification by silica gel column chromatography (petroleum ether/etac: 11/1) gave S10 (2.92 g, 79%) as a white foam: [α] 24 D = (c 1.28, CCl 3 ); 1 NMR (300 Mz, S10
12 CDCl 3 ) δ 7.96 (m, 4), 7.44 (m, 26), 5.93 (m, 2), 5.06 (d, J = 11.4 z, 1), 4.65 (m, 3), 4.15 (d, J = 1.8 z, 1), 3.82 (m, 4), 1.07 (s, 9); 13 C NMR (75 Mz, CDCl 3 ) δ 165.2, 165.0, 138.3, 137.5, 135.5, 133.4, 133.1, 133.0, 130.1, 129.8, 129.7, 129.6, 128.7, 128.4, 128.3, 128.2, 128.0, 127.9, 127.8, 127.7, 127.5, 93.2, 79.7, 75.9, 74.8, 72.7, 72.2, 70.9, 61.7, 26.9, 19.2; RMS (MALDI) m/z calcd for C SiNa [M+Na] +, found Bn Bn TBDPS Bz S10 Bz 1) N 2 4 2,Ac,DMF,rt; 2) CCl 3 CN, DBU, C 2 Cl 2,rt,50% Bn Bn TBDPS Bz N To a solution of S10 (6.42 g, 7.96 mmol) in DMF (75 ml) under stirring at 0 o C, were added N (2.80 ml, mmol) and Ac (2.80 ml, mmol). After stirring for 10 h at rt, the solution was diluted with EtAc and washed with water and brine. The organic layer was dried over Na 2 S 4, filtered, and evaporated in vacuo to give a residue, which was purified by silica gel column chromatography (petroleum ether/etac: 9/1 to 6/1) to give a white foam. The foam was dissolved in C 2 Cl 2 (60 ml), Cl 3 CCN (2.80 ml, mmol) and DBU (0.1 ml, 0.56 mmol) were added. After stirring for 2 h at rt, the solution was evaporated in vacuo to give a residue, which was purified by silica gel column chromatography (petroleum ether/etac: 9/1) to give 5 (3.18 g, 50%) as a white foam: [α] 23 D = 68.4 (c 0.96, CCl 3 ); 1 NMR (300 Mz, CDCl 3 ) δ 8.39 (s, 1), 7.98 (d, J = 7.8 z, 2), 7.59 (m, 5), 7.30 (m, 18), 6.60 (d, J = 3.6 z, 1), 5.80 (dd, J = 3.6, 11.1 z, 1), 5.04 (d, J = 11.4 z, 1), 4.72 (m, 3), 4.19 (m, 2), 4.07 (t, J = 6.6 z, 1), 3.87 (t, J = 7.2 z, 1), 3.78 (m, 1), 1.05 (s, 9); 13 C NMR (100 Mz, CDCl 3 ) δ 165.5, 160.4, 138.3, 137.8, 135.5, 133.2, 133.1, 129.7, 129.6, 128.4, 128.3, 128.2, 128.0, 127.9, 127.8, 127.7, 127.6, 127.5, 94.5, 76.0, 75.0, 73.9, 73.8, 72.5, 70.2, 62.1, 26.9, 19.2; RMS (MALDI) m/z calcd for C N 7 SiCl 3 Na [M+Na] +, found CCl 3 S11
13 Bz SPh S11 1) i) Bu 2 Sn, toluene, reflux, ii) PMBCl, TBAI, 80 o C; 2)BnBr,Na,TF,0 o Ctort PMB SPh Bn 1) BzCl, Et 3 N, DMAP, C 2 Cl 2, 0 o Ctort; 2) DDQ, C 2 Cl 2 / 2, rt 63% from S11 Bz SPh Bn S12 A mixture of S11 3 (293 mg, 0.81 mmol), Bu 2 Sn (325 mg, 1.30 mmol) in toluene (8 ml) was stirred under reflux, using a Deaan-Stark trap, for 9.5 h. The solution was cooled to ca. 80 o C, and then treated with PMBCl (0.56 ml, 4.14 mmol) and n Bu 4 NI (481 mg, 1.30 mmol). After stirring for 12 h at 80 o C, the mixture was concentrated. The residue was stirred with EtAc (100 ml) at 0 o C for 2 h. The solids were removed by filtration and the filtrate was concentrated. Purification of the residue by silica gel column chromatography (petroleum ether/etac: 4/1) gave a colorless syrup. The syrup was dissolved in TF (10 ml) at 0 o C, followed by addition of Na (82 mg, 60%). After the solution was stirred for 30 min at 0 o C, BnBr (0.24 ml, 2.03 mmol) was added. The stirring continued for 17 h at rt, the solution was then diluted with C 2 Cl 2 and washed with brine. The organic layer was dried over Na 2 S 4, filtered, and evaporated in vacuo to give a syrup, which was purified by silica gel column chromatography (petroleum ether/etac: 9/2) to give a colorless syrup. The product above was dissolved in C 2 Cl 2 (5 ml) at 0 o C, followed by addition of DMAP (12 mg, 0.10 mmol), Et 3 N (0.41 ml, 2.87 mmol), and BzCl (0.17 ml, 1.43 mmol). After stirring for 9 h at rt, the solution was diluted with C 2 Cl 2 and washed with brine. The organic layer was dried over Na 2 S 4, filtered, and evaporated in vacuo to give a syrupy, which was purified by silica gel column chromatography (petroleum ether/etac: 19/2) to give a colorless syrup. This syrup was dissolved in C 2 Cl 2 / 2 (6.0 ml/0.36 ml) at rt, and DDQ (358 mg, 1.58 mmol) was added. After stirring for 2 h, the reaction was quenched by addition of saturated aqueous NaC 3 solution. The resulting mixture was diluted with C 2 Cl 2 and washed with brine. The organic layer was dried over Na 2 S 4, filtered, and evaporated in vacuo. The residue was purified by silica gel column chromatography (petroleum ether/etac: 19/2) to give S12 (230 mg, 63%) as a colorless syrupy: [α] 25 D = (c 0.78, CCl 3 ); 1 NMR (300 Mz, CDCl 3 ) δ 8.08 (d, J = 7.2 z, 2), 7.58 (t, J = 7.2 z, 1), 7.47 (m, 4), 7.31 (m, 8), 5.61 (s, 1), 5.22 (t, J = 9.9 z, 1), 4.78 (d, J = 11.1 z, 1), 4.58 (d, J = 12.0 z, 1), 4.40 (m, S12
14 1), 4.07 (d, J = 2.4 z, 1), 4.02 (br, 1), 2.50 (d, J = 8.7 z, 1), 1.28 (d, J = 6.6 z, 3); 13 C NMR (75 Mz, CDCl 3 ) δ 166.6, 137.2, 134.1, 133.2, 131.5, 129.8, 129.1, 128.6, 128.4, 128.1, 128.0, 127.5, 85.1, 79.9, 75.6, 72.6, 70.4, 67.5, 17.4; RMS (MALDI) m/z calcd for C SNa [M+Na] +, found Bz SPh Bn 91% S12 4, TMSTf,4AMS, C 2 Cl 2,-60to-20 o C Bn Bn Bn Bz CA S13 Bn To a mixture of S12 (208 mg, 0.46 mmol), 4 (403 mg, 0.60 mmol), and 4 Å MS, was added dry C 2 Cl 2 (6 ml). The mixture was stirred for 30 min at -60 o C to -20 o C, then TMSTf (0.47 ml, 0.1 M) was added dropwise. After 2.5 h, the reaction was quenched by addition of Et 3 N, and filtered. The filtrate was concentrated in vacuo to give a residue, which was purified by silica gel column chromatography (toluene/c 2 Cl 2 : 1/2) to provide S13 (405 mg, 91%) as a colorless syrup: [α] 24 D = (c 0.99, CCl 3 ); 1 NMR (300 Mz, CDCl 3 ) δ 8.05 (d, J = 7.2 z, 2), 7.64 (t, J = 7.2 z, 1), 7.54 (t, J = 7.5 z, 2), 7.25 (m, 25), 5.50 (s, 1), 5.49 (t, J = 9.6 z, 1), 4.99 (t, J = 8.7 z, 1), 4.62 (m, 9), 4.31 (m, 1), 4.18 (m, 2), 3.86 (d, J = 14.7 z, 1), 3.75 (d, J = 11.1 z, 1), 3.62 (m, 2), 3.41 (m, 3), 1.22 (d, J = 6.3 z, 3); 13 C NMR (75 Mz, CDCl 3 ) δ 166.0, 165.3, 138.0, 127.9, 137.7, 137.6, 134.1, 133.4, 130.9, 129.5, 129.0, 128.6, 128.3, 128.2, 128.1, 128.0, 127.9, 127.8, 127.7, 127.6, 127.4, 127.2, 101.1, 86.5, 82.3, 79.2, 77.9, 77.4, 75.3, 75.0, 74.2, 74.0, 73.5, 73.4, 68.7, 67.8, 40.2, 17.2; RMS (MALDI) m/z calcd for C SClNa [M+Na] +, found SPh Bn Bn Bn Bz CA S13 SPh Bn DABC, Et, 55 o C 86% Bn Bn Bn To a solution of S13 (52 mg, 0.05 mmol) in Et (2.7 ml), was added DABC (93 mg, 0.81 mmol). The solution was stirred at 55 o C for 9 h, and was then diluted with C 2 Cl 2, and washed with 1 N aqueous Cl solution and brine. The organic layer was dried over Na 2 S 4, filtered, and evaporated in vacuo to give a syrup, which was purified by silica gel column chromatography (petroleum ether/etac: 8/1) to give S14 (41 mg, Bz S14 SPh Bn S13
15 86%) as a colorless syrup: [α] 24 D = (c 1.22, CCl 3 ); 1 NMR (300 Mz, CDCl 3 ) δ 8.06 (d, J = 7.2 z, 2), 7.60 (t, J = 7.2 z, 1), 7.47 (t, J = 7.5 z, 2), 7.32 (m, 23), 7.17 (m, 2), 5.50 (t, J = 7.5 z, 1), 5.47 (s, 1), 4.83 (t, J = 10.5 z, 3), 4.71 (d, J = 11.7 z, 1), 4.65 (d, J = 11.1 z, 1), 4.53 (s, 2), 4.51 (d, J = 8.4 z, 1), 4.42 (m, 1), 4.32 (d, J = 7.8 z, 1), 4.25 (d, J = 1.5 z, 1), 4.15 (dd, J = 3.6, 9.9 z, 1), 3.73 (d, J = 7.5 z, 1), 3.62 (dd, J = 4.2, 11.1 z, 1), 3.46 (m, 4), 1.28 (d, J = 6.6 z, 3); 13 C NMR (75 Mz, CDCl 3 ) δ 166.3, 138.6, 138.1, 134.1, 133.1, 130.9, 129.6, 128.9, 128.4, 128.2, 127.8, 127.6, 127.4, 127.2, 104.3, 86.3, 83.7, 79.4, 78.6, 77.1, 75.0, 74.9, 74.8, 74.7, 73.8, 73.4, 73.3, 69.2, 67.7, 17.4; RMS (MALDI) m/z calcd for C S [M+] +, found Bn Bn Bn Bz SPh SPh (1) BnBr, Na, TF, 0 o Ctort; (2)PMBCl,Na,TBAI,DMF,rt PMB Bn Bn 78% Bn Bn Bn S14 Bn 6 Compound S14 (30 mg, 0.03 mmol) was dissolved in TF (2 ml) at 0 o C, followed by addition of Na (3 mg, 60%). After stirring at 0 o C for 30 min, BnBr (0.01 ml, 0.07 mmol) was added. After stirred for 24 h at rt, the mixture was diluted with C 2 Cl 2 and washed with brine. The organic layer was dried over Na 2 S 4, filtered, and evaporated in vacuo. The residue was purified by silica gel column chromatography (petroleum ether/etac: 7/1) to give a colorless syrup (23 mg). The syrup was dissolved in DMF (2 ml) at 0 o C, followed by addition of Na (2 mg, 60%). After stirring for 30 min at 0 o C, PMBCl (8 μl, 0.05 mmol) and Bu 4 NI (19 mg, 0.05 mmol) were added. After stirring for 7 h at rt, the solution was diluted with C 2 Cl 2 and washed with brine. The organic layer was dried over Na 2 S 4, filtered, and evaporated in vacuo. The residue was purified by silica gel column chromatography (petroleum ether/etac: 15/1) to give 6 (26 mg, 78%) as a colorless syrup: [α] 27 D = (c 1.22, CCl 3 ); 1 NMR (300 Mz, CDCl 3 ) δ 7.41 (d, J = 7.5 z, 2), 7.30 (m, 30), 6.79 (d, J = 8.4 z, 2), 5.45 (s, 1), 5.08 (d, J = 11.4 z, 1), 4.98 (d, J = 11.1 z, 1), 4.80 (m, 7), 4.59 (m, 3), 4.38 (d, J = 9.9 z, 1), 4.17 (m, 3), 3.78 (s, 3), 3.69 (m, 5), 3.47 (m, 2), 1.33 (d, J = 6.0 z, 1); 13 C NMR (75 Mz, CDCl 3 ) δ 158.9, 138.3, 138.2, 138.1, 138.0, 137.9, 135.3, 134.5, 130.8, S14
16 130.1, 129.4, 128.7, 128.2, 128.1, 128.0, 127.8, 127.6, 127.5, 127.4, 127.3, 127.2, 126.8, 113.5, 103.4, 86.1, 84.4, 82.4, 80.7, 80.3, 77.8, 75.4, 74.8, 74.7, 74.3, 73.3, 72.9, 69.1, 68.6, 54.9, 17.6; RMS (ESI) m/z calcd for C SNa [M+Na] +, found BnBr,Na,DMF,rt,80% Bn S15 S16 Compound S15 4 (230 mg, 1.82 mmol) was dissolved in DMF (2 ml) at 0 o C, followed by addition of Na (365 mg, 60%). After the solution was stirred for 30 min at 0 o C, BnBr (1.08 ml, 9.10 mmol) was added. After stirring for 3 h at rt, the solution was diluted with C 2 Cl 2 and washed with brine. The organic layer was dried over Na 2 S 4, filtered, and evaporated in vacuo to give an oil, which was purified by silica gel column chromatography (petroleum ether/etac: 50/1) to give a colorless oil S16 (315 mg, 80%). 1 NMR (300 Mz, CDCl 3 ) δ (m, 5), (m, 2), (m, 4), 4.47 (s, 2), (m, 4), 1.22 (s, 3); 13 C NMR (75 Mz, CDCl 3 ) δ 139.5, 134.3, 128.2, 127.3, 127.1, 117.5, 76.6, 63.4, 42.7, S16 Bn 1) i) 3,Me,-78 o C, ii) 2 2 (30%), C 3 C, reflux 2) Ac 2, rt; 3) PMB, Py, 30% (three steps) C Bn CPMB Diene S16 (200 mg, 0.93 mmol) was dissolved in Me (5 ml) and cooled to -78 o C. zone was passed through the solution until a permanent blue color persisted. The solution was then allowed to warm up to room temperature and the solvent was removed under reduced pressure to yield a colorless oil. This oil was dissolved in acetic acid/hydrogen peroxide (30%) (14 ml, v/v 3:4) and heated under reflux for 6 h. Removal of the solvent under reduced pressure gave an oil. Acetic anhydride (5 ml) was added to the oil and the mixture was stirred at rt for 24 h. The solvent was removed under reduced pressure. This crude product was dissolved in pyridine (3 ml), and PMB (200 mg, 1.45 mmol) was added. The mixture was stirred at rt for 24 h. Evaporation of the solvent in vacuo and purification of the residue by silica gel column chromatography (C 2 Cl 2 /Me: 20/1) gave a colorless oil 7 (104 mg, 30% for three steps). 1 NMR 7 S15
17 (300 Mz, CDCl 3 ) δ (m, 7), 6.85 (d, J = 11.7 z, 2), 5.07 (s, 2), (AB, 2), 3.80 (s, 3), (m, 4), 1.52 (s, 3). Bn Bn Bn + Bn Ac Br 2 3 TBAB, K 2 C 3, EtAc/ 2, 50 o C 80% Bn Bn 15 Bn Bn Ac To a solution of the bromide 3 and triterpene 2 (150 mg, 0.22 mmol) in EtAc/ 2 (4 ml/4 ml), were added K 2 C 3 (93 mg, 0.67 mmol) and Bu 4 NBr (146 mg, 0.45 mmol). The mixture was stirred at 40 o C for 12 h, and was then diluted with EtAc, and washed with 1 N aqueous Cl solution and brine. The organic layer was dried over Na 2 S 4, filtered, and evaporated in vacuo to give a yellow solid, which was purified by silica gel column chromatography (toluene/etac: 45/1) to give 15 (184 mg, 80% based on 2) as a white foam: [α] 27 D = 38.1 (c 1.11, CCl 3 ); 1 NMR (300 Mz, CDCl 3 ) δ 7.32 (m, 20), 5.64 (d, J = 4.5 z, 1), 5.33 (brs, 1), 5.26 (t, J = 4.8 z, 1), 4.74 (d, J = 11.4 z, 1), 4.66 (s, 2), 4.59 (m, 3), 4.42 (d, J = 12.3 z, 1), 4.29 (d, J = 11.4 z, 1), 4.10 (dd, J = 6.6, 12.0 z, 1), 3.89 (br, 1), 3.72 (m, 3), 3.52 (dd, J = 3.0, 11.7 z, 1), 3.42 (d, J = 9.3 z, 1), 3.10 (d, J = 8.7 z, 1), 2.87 (d, J = 10.5 z, 1), 2.67 (br, 1), 2.27 (d, J = 14.1 z, 1), 2.03, 1.20, 1.14, 0.89, 0.88, 0.85, 0.76 (s, each 3); 13 C NMR (75 Mz, CDCl 3 ) δ 175.8, 169.2, 143.3, 138.9, 138.3, 137.8, 137.7, 128.3, 128.1, 127.7, 127.6, 127.4, 127.3, 127.2, 122.5, 91.1, 79.2, 74.9, 73.5, 72.7, 71.8, 71.6, 71.3, 71.2, 69.0, 61.3, 47.8, 46.8, 46.7, 45.6, 41.9, 41.8, 41.0, 39.2, 39.0, 36.5, 33.7, 33.0, 32.4, 31.9, 30.5, 27.6, 25.6, 23.5, 23.4, 22.5, 20.9, 17.5, 16.9, 16.0, 13.6; RMS (ESI) m/z calcd for C Na [M+Na] +, found S16
18 in dry C 2 Cl 2 (10 ml) at -40 o C to -20 o C, 40 min later, TMSTf (0.49 ml, 0.1 M) was added dropwise. After stirring for 2 h, the reaction was quenched by addition of Et 3 N. The mixture was filtered. The filtrate was concentrated in vacuo and purified by silica gel column chromatography (toluene/etac: 60/1) to give 16 (1.43 g, 96%) as a white foam: [α] 22 D = 23.1 (c 0.99, CCl 3 ); 1 NMR (300 Mz, CDCl 3 ) δ 7.31 (m, 35), 5.62 (d, J = 4.5 z, 1), 5.32 (brs, 1), 5.26 (t, J = 5.4 z, 1), 5.05 (t, J = 8.1 z, 1), 4.70 (m, 14 ), 4.34 (d, J = 7.8 z, 1), 4.09 (m, 2), 3.68 (m, 9), 3.51 (dd, J = 2.4, 11.4 z, 1), 3.41 (m, 1), 3.14 (d, J = 9.3 z, 1), 3.01 (d, J = 9.0 z, 1), 2.86 (d, J = 10.8 z, 1), 2.03, 1.21, 1.11, 0.89, 0.87, 0.84, 0.74 (s, each 3); 13 C NMR (75 Mz, CDCl 3 ) δ 175.8, 169.2, 165.5, 143.2, 140.1, 138.5, 138.1, 138.0, 137.8, 137.7, 128.4, 128.3, 128.2, 127.9, 127.8, 127.7, 127.6, 127.4, 127.3, 127.1, 126.6, 122.7, 101.9, 91.2, 82.6, 81.7, 79.5, 78.1, 75.3, 75.1, 74.9, 74.6, 73.2, 73.1, 72.8, 71.8, 71.3, 71.2, 69.0, 68.7, 61.4, 47.9, 47.4, 46.7, 45.6, 42.2, 42.0, 41.7, 40.9, 40.5, 39.2, 36.5, 33.6, 33.0, 32.5, 31.9, 30.5, 27.6, 25.7, 23.4, 22.5, 20.8, 17.4, 16.9, 16.2, 13.6; RMS (ESI) m/z calcd for C Cl [M+] +, found Bn DABC, Et, 50 o C, 100% Bn Bn Bn Bn CA Bn 16 Bn Bn Ac Bn Bn Bn Bn Bn Bn 17 Ac To a solution of 16 (135 mg, 0.09 mmol) in Et (4.4 ml), was added DABC (148 mg, 1.32 mmol). The solution was stirred at 50 o C for 32 h, then evaporated in vacuo to give a residue, which was purified by silica gel column chromatography (toluene/etac: 25/1) to give 17 (128 mg, 100%) as a white foam: [α] 22 D = 26.6 (c 0.98, CCl 3 ); 1 NMR (300 Mz, CDCl 3 ) δ 7.30 (m, 35), 5.63 (d, J = 4.2 z, 1), 5.33 (brs, 1), 5.26 (t, J = 5.4 z, 1), 5.00 (d, J = 11.4 z, 1), 4.85 (m, 2), 5.54 (m, 11), 4.29 (d, J = 6.6 z, 1), 4.10 (m, 2), 3.66 (m, 9), 3.41 (m, 2), 3.15 (d, J = 9.3 z, 1), 2.86 (d, J = 9.9 z, 1), 2.71 (m, 1), 2.04 (s, 3), 1.25, 1.12, 0.98, 0.89, 0.88, 0.75 (s, each 3); 13 C NMR (75 Mz, CDCl 3 ) δ 175.8, 169.2, 143.2, 139.6, 138.7, 138.4, 138.1, 138.0, 137.7, 137.6, 128.3, 128.2, 128.1, 128.0, 127.9, 127.8, 127.7, 127.5, 127.4, S17
19 CCl 3 ); 1 NMR (300 Mz, CDCl 3 ) δ 7.30 (m, 35), 5.63 (d, J = 4.2 z, 1), 5.33 (brs, 1), 5.26 (t, J = 5.4 z, 1), 5.00 (d, J = 11.4 z, 1), 4.85 (m, 2), 5.54 (m, 11), 4.29 (d, J = 6.6 z, 1), 4.10 (m, 2), 3.66 (m, 9), 3.41 (m, 2), 3.15 (d, J = 9.3 z, 1), 2.86 (d, J = 9.9 z, 1), 2.71 (m, 1), 2.04 (s, 3), 1.25, 1.12, 0.98, 0.89, 0.88, 0.75 (s, each 3); 13 C NMR (75 Mz, CDCl 3 ) δ 175.8, 169.2, 143.2, 139.6, 138.7, 138.4, 138.1, 138.0, 137.7, 137.6, 128.3, 128.2, 128.1, 128.0, 127.9, 127.8, 127.7, 127.5, 127.4, 127.3, 127.1, 126.8, 122.6, 104.4, 91.1, 84.5, 81.9, 79.1, 75.4, 75.0, 74.9, 74.8, 73.2, 72.6, 72.5, 71.7, 71.3, 71.1, 69.0, 61.4, 47.8, 47.6, 46.7, 45.6, 42.0, 41.7, 40.9, 39.2, 36.5, 33.6, 32.9, 32.4, 31.8, 30.5, 27.5, 25.6, 23.4, 22.5, 20.8, 17.4, 17.0, 16.2, 13.9; RMS (MALDI) m/z calcd for C Na [M+Na] +, found Bn Bn Bn Bn Bn 17 Bn Bn Ac TMSTf, C 2 Cl 2, -40to-20 o C, 65% TBDPS Bn Bn N CCl 3 Bn Bn Bn TBDPS Bn To a mixture of 17 (316 mg, 0.22 mmol), 5 (368 mg, 0.43 mmol), and 4 Å MS, was added dry C 2 Cl 2 (6 ml). The mixture was stirred for 30 min at -40 o C to -20 o C, then TMSTf (0.22 ml, 0.1 M) was added dropwise, followed by addition of 5 (368 mg, 0.43 mmol) in C 2 Cl 2 (2 ml) 30 min later, and another potion of 5 (184 mg, 0.22 mmol) in C 2 Cl 2 (1 ml) after 1 h. The stirring continued for 2.5 h, the reaction was then quenched by addition of Et 3 N. The mixture was filtrated. The filtrate was concentrated in vacuo and purified by silica gel column chromatography (petroleum ether/etac: 9/1) to give 18 (300 mg, 65%) as a white foam: [α] 23 D = 24.1 (c 1.04, CCl 3 ); 1 NMR (500 Mz, CDCl 3 ) δ 7.88 (d, J = 7.4 z, 2), 7.32 (m, 53), 7.05 (m, 2), 6.94 (m, 3), 5.79 (t, J = 9.0 z, 1), 5.67 (d, J = 4.4 z, 1), 5.31 (brs, 1), 5.27 (t, J = 5.2 z, 1), 5.04 (m, 2), 4.60 (m, 13), 4.39 (m, 5), 4.22 (d, J = 7.6 z, 1), 4.18 (d, J = 2.0 z, 1), 4.12 (m, 1), 4.02 (d, J = 4.2 z, 1), 3.93 (t, J = 9.0 z, 1), 3.74 (m, 4), 3.64 (m, 2), 3.59 (d, J = 3.5 z, 1), 3.54 (m, 3), 3.49 (m, 1), 3.41 (m, 2), 3.21 (m, 1), 2.86 (dd, J = 3.6, 13.4 z, 1), 2.76 (d, J = 9.5 z, 1), 2.08, 1.15, 1.12 (s, each 3), 1.05 (s, 5 Bz Bn Bn Bz Bn 18 Bn Bn Ac S18
20 9), 0.88, 0.87, 0.77, 0.60 (s, each 3); 13 C NMR (125 Mz, CDCl 3 ) δ 175.9, 169.2, 164.9, 143.3, 140.7, 140.4, 138.8, 138.7, 138.3, 138.0, 137.9, 137.8, 135.5, 135.4, 133.3, 132.8, 132.7, 130.1, 129.7, 128.3, 128.2, 128.1, 129.9, 127.8, 127.7, 127.6, 127.5, 127.4, 127.3, 127.2, 127.1, 127.0, 126.7, 126.3, 122.9, 103.8, 100.6, 91.2, 85.6, 83.5, 80.0, 79.9, 78.4, 77.7, 75.0, 74.5, 74.1, 74.0, 73.2, 73.0, 72.7, 72.5, 72.0, 71.7, 71.6, 71.5, 71.3, 69.2, 69.1, 61.2, 61.1, 48.0, 47.6, 46.9, 45.7, 42.5, 42.2, 41.8, 41.1, 39.4, 36.5, 33.8, 33.0, 32.6, 32.0, 30.6, 29.6, 27.7, 26.9, 25.7, 23.6, 23.5, 22.6, 20.9, 19.1, 17.4, 17.1, 16.2, 13.0; RMS (MALDI) m/z calcd for C SiNa [M+Na] +, found Bn Bn Bn TBDPS Bn Bn Bn Bz 18 Bn Bn Ac DBU, Me, C 2 Cl 2,97% Bn Bn Bn TBDPS Bn Bn Bn Bz 19 Bn Bn Bn Bn DBU (0.08 ml, 0.50 mmol) was added to a solution of 18 (154 mg, 0.07 mmol) in Me/C 2 Cl 2 (0.5 ml/1.5 ml) at rt. After stirring for 1 h, the solution was diluted with C 2 Cl 2 and washed with 1 N aqueous Cl solution and brine. The organic layer was dried over Na 2 S 4, filtered, and evaporated in vacuo. The residue was purified by silica gel column chromatography (petroleum ether/etac: 5/1 to 4/1) to give 19 (147 mg, 97%) as a white foam: [α] 23 D = 44.0 (c 1.05, CCl 3 ); 1 NMR (300 Mz, CDCl 3 ) δ 7.88 (d, J = 7.2 z, 2), 7.33 (m, 55), 6.91 (m, 3), 5.80 (dd, J = 7.8, 9.9 z, 1), 5.51 (d, J = 6.9 z, 1), 5.32 (brs, 1), 5.05 (m, 2), 4.56 (m, 18), 4.25 (d, J = 8.1 z, 1), 4.19 (s, 1), 4.06 (m, 1), 4.01 (d, J = 2.7 z, 1), 3.92 (t, J = 9.6 z, 1), 3.62 (m, 14), 3.20 (m, 1), 2.88 (d, J = 9.0 z, 1), 2.75 (d, J = 9.0 z, 1), 2.50 (brs, 1), 1.14 (s, 6), 1.05 (s, 9), 0.90 (s, 6), 0.78, 0.57 (s, each 3); 13 C NMR (100 Mz, CDCl 3 ) δ 176.3, 164.9, 143.4, 140.7, 140.4, 138.8, 138.7, 138.3, 138.1, 138.0, 137.9, 137.8, 135.5, 135.4, 133.3, 132.8, 132.7, 130.2, 129.7, 129.6, 128.4, 128.3, 128.2, 128.1, 127.9, 127.8, 127.7, 127.6, 127.5, 127.4, 127.2, 127.1, 126.7, 126.3, 122.9, 103.8, 100.6, 94.2, 85.6, 83.5, 80.1, 79.9, 79.8, 78.4, 77.8, 75.0, 74.6, 74.1, 74.0, 73.3, 73.0, 72.9, 72.7, 72.5, 72.0, S19
21 71.7, 71.6, 71.4, 69.6, 69.1, 63.3, 61.2, 48.0, 47.6, 46.9, 45.8, 42.6, 42.3, 41.9, 41.2, 39.4, 36.5, 33.9, 33.0, 32.5, 32.1, 30.6, 29.6, 27.6, 27.0, 25.7, 23.7, 23.5, 22.8, 19.1, 17.4, 17.2, 16.2, 13.0; RMS (MALDI) m/z calcd for C Si 20 Na [M+Na] +, found Bn Bn Bn TBDPS Bn Bn Bn Bz Bn 19 Bn Bn 6, NIS, TMSTf,C 2 Cl 2, -40 to -20 o C, 81% Bn Bn Bn TBDPS Bn Bn Bn Bz Bn 20 PMB Bn Bn Bn Bn To a mixture of 19 (90 mg, 0.04 mmol), 6 (127 mg, 0.13 mmol), and 4 Å MS in dry C 2 Cl 2 (2 ml) at -40 o C to -20 o C, was added NIS (29 mg, 0.13 mmol). After stirring for 30 min, TMSTf (0.04 ml, 0.05 M) was added, and the stirring continued at this temperature for 6.5 h. The reaction was quenched by addition of Et 3 N. The mixture was filtered. The filtrate was diluted with C 2 Cl 2 and washed with 10% aqueous Na 2 S 2 3 solution and brine. The organic layer was dried over Na 2 S 4, filtered, and evaporated in vacuo. The residue was purified by silica gel column chromatography (petroleum ether/etac: 6.5/1) to give 20 (103 mg, 81%) as a white foam: [α] 23 D = 8.3 (c 1.10, CCl 3 ); 1 NMR (500 Mz, CDCl 3 ) δ 7.88 (d, J = 4.2 z, 2), 7.55 (d, J = 6.7 z, 2), 7.46 (m, 5), 7.24 (m, 73), 7.05 (m, 2), 6.94 (m, 3), 6.76 (d, J = 8.6 z, 2), 5.91 (s, 1), 5.79 (dd, J = 7.9, 10.0 z, 1), 5.28 (s, 1), 5.05 (m, 3), 4.96 (d, J = 11.0 z, 1), 4.84 (m, 5), 4.62 (m, 15), 4.39 (m, 9), 4.22 (d, J = 7.6 z, 1), 4.18 (m, 2), 4.03 (m, 2), 3.93 (t, J = 9.0 z, 1), 3.82 (dd, J = 1.8, 14.4 z, 2), 3.75 (t, J = 8.6 z, 2), 3.68 (s, 3), 3.67 (m, 12), 3.44 (m, 8), 3.21 (m, 1), 2.86 (dd, J = 3.3, 13.8 z, 1), 2.75 (d, J = 9.5 z, 1), 1.36 (d, J = 6.3 z, 3), 1.16, 1.10 (s, each 3), 1.05 (s, 9), 0.86, 0.84, 0.77, 0.60 (s, each 3); 13 C NMR (100 Mz, CDCl 3 ) δ 175.7, 164.9, 159.1, 143.5, 140.7, 140.5, 138.7, 138.6, 138.5, 138.4, 138.3, 138.2, 138.1, 138.0, 137.8, 135.5, 135.4, 133.3, 132.8, 132.7, 130.4, 130.2, 129.7, 129.5, 128.3, 128.2, 128.1, 128.0, 127.9, 127.8, 127.7, 127.6, 127.5, 127.4, 127.2, 127.1, 126.8, 126.3, 122.8, 113.7, 103.9, 103.3, Bn Bn Bn S20
22 100.6, 98.5, 91.3, 85.7, 84.7, 83.6, 82.9, 80.9, 80.1, 80.0, 78.5, 78.1, 77.9, 77.8, 76.8, 75.6, 75.0, 74.9, 74.8, 74.6, 74.3, 74.1, 74.0, 73.7, 73.3, 73.2, 73.1, 72.7, 72.6, 72.5, 71.7, 71.6, 71.4, 69.2, 68.8, 61.2, 58.7, 55.1, 48.0, 47.6, 46.9, 45.7, 42.6, 42.3, 41.8, 41.2, 39.5, 36.5, 33.8, 33.1, 32.6, 32.2, 31.9, 31.4, 30.6, 30.2, 29.7, 29.3, 29.1, 27.7, 27.0, 25.9, 23.6, 23.5, 22.7, 22.6, 19.1, 17.9, 17.5, 17.3, 16.3, 14.1, 13.1; RMS (MALDI) m/z calcd for C Si 30 Na [M+Na] +, found Bn Bn Bn TBDPS Bn Bn Bn Bn Bn Bn Bz PMB Bn 20 Bn Bn Bn Bn 1) NaMe, Me/C 2 Cl 2,reflux 2)BnBr,Na,TF,0 o Ctort,51% Bn Bn Bn TBDPS Bn Bn Bn Bn 21 Bn PMB Bn Bn Bn Bn To a solution of 20 (80 mg, 0.03 mmol) in C 2 Cl 2 /Me (2 ml/2 ml) was added a solution of NaMe in Me (0.2 M, 0.54 ml). The mixture was stirred for 3 d at reflux. After cooling to rt, the mixture was neutralized with Dowex-50 ( + ). Filtration, concentration in vacuo, and purification by silica gel column chromatography (toluene/etac: 40/1 to 30/1) provided a white foam (47 mg, 61%) and 20 (15 mg, 19%). The white foam was dissolved in TF (1.5 ml) at 0 o C, followed by addition of Na (8 mg, 60%) and BnBr (0.05 ml, 0.42 mmol). After stirring for 24 h at rt, the solution was diluted with C 2 Cl 2 and washed with brine. The organic layer was dried over Na 2 S 4, filtered, and evaporated in vacuo. The residue was purified by silica gel column chromatography (toluene/etac: 40/1) to give 21 (39 mg, 51% based on 20) as a white foam: [α] 25 D = 6.9 (c 0.94 CCl 3 ); 1 NMR (300 Mz, CDCl 3 ) δ 7.25 (m, 84), 6.95 (m, 3), 6.76 (d, J = 11.7 z, 2), 5.91 (s, 1), 5.29 (brs, 1), 4.65 (m, 35), 4.17 (m, 2), 4.04 (m, 3), 3.66 (s, 3), 3.62 (m, 26), 2.84 (d, J = 13.5 z, 1), 2.73 (d, J = 8.4 z, 1), 1.37 (d, J = 5.7 z, 3), 1.17, 1.07 (s, each 3), 1.01 (s, 9), 0.86, 0.84, 0.77, 0.64 (s, each 3); 13 C NMR (100 Mz, CDCl 3 ) δ 175.8, 159.2, 143.6, 140.7, 139.7, 139.3, 139.1, 138.8, 138.7, 138.5, 138.4, 138.3, 138.2, 138.1, 135.6, 135.5, 133.3, 132.9, 130.5, 129.8, 129.6, 128.6, 128.5, 128.4, 128.3, 128.2, 128.1, 128.0, 127.9, 127.8, 127.7, 127.6, Bn Bn Bn S21
23 127.5, 127.4, 127.3, 127.2, 127.0, 126.5, 123.0, 113.8, 104.3, 103.5, 102.6, 98.6, 91.4, 86.3, 84.8, 83.5, 83.0, 82.6, 81.1, 81.0, 79.9, 78.6, 78.5, 78.1, 75.8, 75.6, 75.5, 75.1, 74.9, 74.8, 74.4, 74.3, 73.9, 73.8, 73.6, 73.4, 73.1, 72.7, 72.6, 72.3, 71.5, 69.4, 68.9, 68.8, 61.4, 58.9, 55.3, 48.2, 47.7, 47.0, 45.8, 42.5, 41.9, 41.3, 39.6, 36.7, 33.9, 33.2, 32.7, 32.3, 30.8, 29.8, 27.8, 27.1, 26.0, 23.8, 23.7, 22.7, 19.2, 18.0, 17.7, 17.4, 16.4, 13.3; RMS (MALDI) m/z calcd for C SiNa [M+Na] +, found Bn Bn Bn TBDPS Bn Bn Bn Bn Bn Bn Bn Bn Bn TBAF, TF, rt, 98% Bn Bn Bn Bn Bn PMB Bn Bn PMB Bn Bn Bn Bn Bn Bn Bn 21 Bn Bn Bn S17 Bn To a solution of 21 (150 mg, 0.05 mmol) in TF (3 ml) at rt was added Bu 4 NF (1.0 M in TF, 0.3 ml, 0.3 mmol). The solution was stirred at this temperature for 2 h, and was then diluted with C 2 Cl 2, and washed with water. The organic layer was separated and the aqueous layer was extracted with C 2 Cl 2. The combined organic layer was washed with brine, dried over Na 2 S 4, and concentrated in vacuo. The residue was purified by silica gel column chromatography (petroleum ether/etac, 3:1) to afford S17 (133 mg, 98%) as a white foam. [α] 27 D = 15.1 (c 1.00, CCl 3 ); 1 NMR (300 Mz, CDCl 3 ): δ (m, 77 ), 6.76 (d, J = 8.7 z, 2 ), 5.88 (br s, 1 ), 5.30 ( br s, 1), (m, 38), (m, 2), 4.03 (t, J = 10.4 z, 1), (m, 34), (m, 2), 1.32 (d, J = 6.6 z, 3), 1.24 (s, 3), 1.09 (s, 3), 0.93 (s, 3), 0.87 (s, 3), 0.85 (s, 3), 0.77 (s, 3); 13 C NMR (75 Mz, CDCl 3 ): δ 175.6, 159.0, 143.4, 139.9, 139.3, 138.7, 138.6, 138.5, 138.3, 138.2, 138.1, 138.0, 137.9, 130.4, 129.3, 128.4, 128.3, 128.2, 128.2, 128.1, 128.0, 127.9, 127.8, 127.7, 127.6, 127.6, 127.5, 127.5, 127.4, 127.3, 127.2, 127.2, 126.8, 122.7, 113.6, 104.1, 103.3, 102.7, 98.4, 91.4, 86.2, 84.6, 83.3, 82.8, 82.2, 80.8, 80.7, 79.6, 78.4, 78.3, 78.0, 75.6, 75.5, 75.1, 75.0, 74.9, 74.8, 74.3, 73.6, 73.3, 73.3, 72.8, 72.5, 72.3, 71.3, 69.3, 68.7, 62.1, 58.8, 55.1, 47.9, 47.5, 46.8, 45.7, 42.4, S22
24 41.8, 41.1, 39.4, 36.5, 33.7, 33.0, 32.5, 32.1, 30.6, 29.6, 27.6, 25.8, 23.5, 22.5, 17.9, 17.5, 17.2, 16.2, 13.5; RMS (MALDI) calcd for C Na [M+Na] + : , found Bn Bn Bn Bn Bn Bn Bn Bn Bn Bn PMB Bn Bn Bn S17 Bn Bn 7, C 6 2 Cl 3 CCl, Et 3 N, toluene, 2 h; then DMAP, 2 h, 96% PMB Bn Bn Bn Bn Bn Bn Bn Bn Bn Bn Bn PMB Bn Bn Bn 22 Bn Bn To a solution of 7 (36 mg, 0.10 mmol) and triethylamine (17 μl, 0.12 mmol) in toluene (0.5 ml) at room temperature was added 2,4,6-trichlorobenzoyl chloride (17 μl, 0.11 mmol). After stirring for 2 h, a solution of S17 (133 mg, mmol) and DMAP (17 mg, 0.14 mmol) in toluene (3 ml) was injected to the reaction vessel, and the stirring continued for 1 h. The mixture was concentrated and purified by silica gel column chromatography (petroleum ether/etac, 4:1) to afford 22 (144 mg, 96%) as a white foam. 1 NMR (300 Mz, CDCl 3 ) δ (m, 84), 6.78 (d, J = 7.5 z, 2), 6.76 (d, J = 8.7 z, 2), 5.89 (br s, 1), (m, 1), (m, 50), 4.03 (t, J = 10.4 z, 1), (m, 40), (m, 6), 1.34 (d, J = 5.7 z, 3), 1.22 (s, 3), 1.09 (s, 3), 0.90 (s, 3), 0.86 (s, 3), 0.84 (s, 3), 0.76 (s, 3); RMS (MALDI) calcd for C Na [M+Na] + : , found PMB Bn Bn Bn Bn Bn Bn Bn Bn Bn Bn PMB Bn Bn Bn Bn 22 Bn Bn TFA,C 2 Cl 2 /C 6 5 Me, -20 o C, 95% Bn Bn Bn Bn Bn Bn Bn Bn Bn Bn Bn Bn Bn Bn 23 Bn Bn S23
25 To a solution of 22 (80 mg, mmol) in C 2 Cl 2 /C 6 5 Me (2 ml, v/v 1:1) at -20 o C was added trifluoroacetic acid (0.2 ml). The mixture was stirred at this temperature for 3 h, and was then quenched by the addition of NaC 3. The resulting solution was extracted with C 2 Cl 2, and the combined extracts were washed with brine. The organic layer was dried with Na 2 S 4 and concentrated in vacuo. The residue was purified by silica gel column chromatography (C 2 Cl 2 /Me, 20:1) to afford 23 (70 mg, 95%) as a white foam: 1 NMR (300 Mz, CDCl 3 ): δ (m, 80), 5.85 (brs, 1), 5.29 (brs, 1), (m, 68), (m, 2), (m, 3), 1.35 (s, 3), 1.31 (s, 3), 1.23 (s, 3), 1.09 (s, 3), (s, 3), 0.86 (s, 3), 0.87 (s, 3), 0.75 (s, 3). 23 Bn Bn 2,4,6-(C 6 2 Cl 3 )CCl Et Bn Bn 3 N, DMAP. 50% Bn Bn Bn Bn Bn + Bn Bn Bn Bn Bn Bn (S) (R) Bn Bn Bn Bn Bn Bn Bn Bn Bn Bn 24a Bn Bn Bn 24b Bn Bn Bn To a solution of 23 (40 mg, mmol) and triethylamine (11 μl, 0.08 mmol) in toluene (1 ml) at room temperature was added 2,4,6-trichlorobenzoyl chloride (11 μl, 0.07 mmol). After stirring for 12 h, the mixture was diluted with toluene (14 ml), and then DMAP (11 mg, 0.09 mmol) was added to the reaction vessel, and the stirring continued for 12 h. The resulting mixture was concentrated and purified by silica gel column chromatography (petroleum ether/etac, 5:1) to afford 24 (20 mg, 50%, 24a:24b = 1 : 1) as a white foam. 24a: 1 NMR (300 Mz, CDCl 3 ): δ (m, 80), 5.73 (brs, 1), 5.48 (t, J = 9.6 z, 1 ), 5.33 (brs, 1), (m, 1 ), (m, 1 ), (m, 68 ), (m, 2 ), (m, 1 ), (m, 1 ), 1.34 (s, 3), 1.23 (s, 3), 1.09 (s, 3), 0.91 (s, 3), 0.90 (s, 3 ), 0.73 (s, 3); RMS (MALDI) calcd for C Na [M+Na] + : , found b: 1 NMR (300 Mz, CDCl 3 ): δ (m, 80), 5.65 (brs, 1), (m, 3 ), S24
26 (m, 3 ), (m, 70 ), (m, 2 ), (m, 2 ), (m, 1 ), 1.38 (s, 3), 1.23 (s, 3), 1.10 (s, 3), 0.81 (s, 3), 0.73 (s, 3 ); 24a Pd() 2, EA/ethanol, 80% (S) Lobatoside E (1) To a solution of 24a (10 mg, mmol) in EtAc/ethanol (1 ml, v/v 1:1) at room temperature was added Pd() 2 (3 mg). The suspension was stirred under hydrogen pressure for 14 h and then filtered. The filtrate was concentrated, the residue was purified by flash chromatography on DS-silica gel (Me/ 2, 3:1) to afford Lobataside E (1) (4 mg, 80%). Lobataside E (1): [α] 22 D = 6.1 (c 0.20, pyridine) ([α] 22 D = 7.01 (c 0.27, pyridine)) 6 ; 1 NMR (500 Mz, Pyridiene-D 5 / D 2 ): δ 6.09 (s, 1 ), 6.01 (d, J = 6.4 z, 1 ), 6.00 (t, J = 9.7 z, 1 ), 5.48 ( br s, 1 ), 5.17 (br s, 1 ), 5.14 (d, J = 7.4 z, 1 ), 5.09 (d, J = 7.5 z, 1 ), 5.01 (d, J = 7.8 z, 1 ), 4.88 (brs, 1 ), 4.82 (dd, J = 6.8, J = 12.1 z, 1 ), 4.73 (m, 1 ), (m, 2 ), 4.53 (dd, J = 9.8, J = 7.8 z, 1 ), (m, 3 ), (m, 8 ), (m, 6 ), (m, 4 ), 3.75 (m, 1 ), 3.36 (d, J = 15.0 z, 1 ), 3.33 (d, J = 14.7 z, 1 ), 3.23 (d, J = 15.5 z, 1 ), (m, 1 ), 3.04 (d, J = 15.5 z, 1 ), 2.03 (s, 3 ), 1.66 (s, 3 ), 1.54 (s, 3 ), 1.53 (d, J = 6.4 z, 3 ), 1.36 (s, 3 ), 1.24 (s, 3 ), 0.93 (s, 3 ), 0.88 (s, 3 ); 13 C NMR (125 Mz, Pyridiene-D 5 ): δ 176.2, 171.3, 170.8, 144.1, 123.2, 106.1, 105.7, 105.1, 102.0, 94.5, 83.0, 82.2, 79.0, 77.9, 77.6, 77.6, 77.2, 76.7, 75.1, 75.0, 74.9, 73.5, 73.3, 73.1, 72.0, 71.7, 71.5, 70.9, 70.7, 70.3, 68.8, 67.9, 66.7, 66.4, 64.6, 62.6, 62.4, 48.4, 47.6, 47.5, 47.1, 46.9, 46.1, 44.1, 42.7, 42.2, 41.5, 39.9, 36.9, 34.1, 33.3, 33.0, 32.2, 30.7, 28.9, 26.0, 25.5, 23.9, 23.4, 22.8, 18.8, 18.4, 17.7, 17.4, 15.4; RMS (MALDI) calcd for C Na [M+Na] + : , found S25
27 24b Pd() 2, EA/ethanol, 80% (R) 25 To a solution of 24b (10 mg, mmol) in EtAc/ethanol (1 ml, v/v 1:1) at room temperature was added Pd() 2 (3 mg). The suspension was stirred under hydrogen pressure for 14 h and then filtered. The filtrate was concentrated, the residue was purified by flash chromatography on DS-silica gel (Me/ 2, 3:1) to afford 25 (4 mg, 80%). 25: [α] 22 D = 1.3 (c 0.20, pyridine); 1 NMR (500 Mz, pyridiene-d 5 /D 2 ): δ 6.16 (s, 1 ), 6.00 (d, J = 5.5 z, 1 ), 5.97 (t, J = 10.0 z, 1 ), 5.47 ( br s, 1 ), 5.17 (br s, 1 ), 5.13 (d, J = 6.5 z, 1 ), 5.08 (d, J = 7.3 z, 1 ), 5.05 (d, J = 7.8 z, 1 ), 4.88 (brs, 1 ), 4.77 (m, 2 ), 4.63 (m, 2 ), 4.56 (m, 1 ), (m, 20 ), (m, 7 ), 3.40 (d, J = 16.7 z, 1 ), 3.35 (d, J = 14.3 z, 1 ), 3.23 (d, J = 18.0 z, 1 ), (m, 3 ), 1.98 (s, 3 ), 1.68 (s, 3 ), 1.53 (s, 3 ), 1.48 (d, J = 5.2 z, 3 ), 1.28 (s, 3 ), 1.25 (s, 3 ), 0.91 (s, 3 ), 0.87 (s, 3 ); 13 C NMR (125 Mz, pyridine-d 5 ): δ 176.1, 171.2, 170.9, 144.0, 123.1, 106.2, 106.0, 105.0, 101.7, 94.3, 82.8, 81.6, 79.3, 78.0, 77.7, 77.5, 76.9, 76.3, 75.1, 75.0, 74.6, 73.5, 73.3, 73.0, 72.0, 71.4, 70.9, 70.5, 70.4, 69.7, 68.7, 67.7, 66.5, 66.5, 64.2, 62.5, 62.2, 48.4, 47.4, 47.0, 47.0, 46.5, 46.0, 44.1, 42.6, 42.1, 41.1, 39.7, 37.1, 33.9, 33.3, 32.8, 31.9, 30.5, 28.5, 25.9, 25.2, 23.8, 23.3, 22.7, 18.7, 18.3, 17.5, 17.2, Table S1. Comparison of the diagnostic 1 NMR signals of the synthetic 1, 25, and the natural Lobatoside E. Position Natural product 6 Synthetic 1 Synthetic 25 28Rha brs 6.09 brs 6.16 brs 28Ara d (6) 6.01 d (6.4) 6.00 d (5.5) S26
28 28Rha t (10) 6.00 t (9.7) 5.97 t (10) -12 ca Rha dd (1.5, 3) 5.17 brs 5.17 brs 3Glc d (8) 5.14 d (7.4) 5.13 d (6.5) 3Gal d (7.5) 5.09 d (7.5) 5.08 d (7.3) 28Glc d (8) 5.01 d (7.8) 5.05 d (7.8) brs 4.88 brs 4.88 brs 3Gla dd (2, 12) 4.73 m 4.77 m 4.82 dd (7, 12) 4.82 dd (6.8, 12.1) 4.77 m Dicrotalic acid moiety 2 (4 ) 3.01 d (16) 3.04 d (15.5) 3.12 d (17) 3.30 d (16) 3.33 d (14.7) 3.35 d (14.3) 4 (2 ) 3.19 d (17) 3.23 d (15.5) 3.23 d (18) 3.32 d (17) 3.36 d (15) 3.40 d (16.7) s 2.03 s 1.98 s s 1.54 s 1.53 s s 1.66 s 1.68 s s 1.24 s 1.25 s s 1.36 s 1.31 s s 0.93 s 0.91 s s 0.88 s 0.87 s Table S2. Comparison of the 13 C NMR data of the synthetic 1, 25, and the natural Lobatoside E. Position Natural product 6 Synthetic 1 Synthetic 25 C C a C S27
29 C C C C C C C C C C C C C C C C C C C C C C C C C C C Dicrotalic acid moiety S28
30 a Glc Glc Glc Glc a 3Glc Glc Gal Gal Gal Gal a 3Gal Gal Ara Ara Ara Ara Ara Rha Rha Rha Rha Rha S29
31 28Rha Glc Glc Glc Glc a 28Glc Glc a) These values may be interchanged. References (1) Yang, G. B.; Kong, F. Z. Bioorg. Med. Chem. Lett. 2006, 13, 909. (2) Timmers, C. M.; Wigchert, S. C. M.; Leeuwenburgh, M. A.; Van der Marel, G.; Van Boom, J.. Eur.J. rg. Chem. 1998, 58, 91. (3) Yang, Z. Y.; Yu, B. Carbohydr. Res. 2001, 333, 105. (4) Lewer, P.; MacMillan, J. J. Chem. Soc., Perkin Trans , (5) Nicolaou, K. C.; Koumbis, A. E.; Takayanagi, M.; Natarajan, S.; Jain, N. F.; Bando, T.; ughes, R.; Winssinger, N.; Natarajan, S.; Koumbis, A. E. Chem. Eur. J. 1999, 5, (6) Fujioka, T.; Iwamoto, M.; Iwase, Y.; achiyama, S.; kabe,.; Yamauchi. T.; Mihashi, K. Chem. Pharm. Bull. 1989, 37, S30
32 PPM PDF 文件以 "FinePrint pdffactory Pro" 试用版创建 S31
33 S32
34 PPM PDF 文件以 "FinePrint pdffactory Pro" 试用版创建 S33
35 PPM PDF 文件以 "FinePrint pdffactory Pro" 试用版创建 S34
36 S35
37 S36
38 PPM PDF 文件以 "FinePrint pdffactory Pro" 试用版创建 S37
39 PPM PDF 文件以 "FinePrint pdffactory Pro" 试用版创建 S38
40 S39
41 S40
42 S41
43 PPM PDF 文件以 "FinePrint pdffactory Pro" 试用版创建 S42
44 S43
45 PPM PDF 文件以 "FinePrint pdffactory Pro" 试用版创建 S44
46 S45
47 Bn Ac Bn S PPM S46
48 PPM PDF 文件以 "FinePrint pdffactory Pro" 试用版创建 S47
49 PPM PDF 文件以 "FinePrint pdffactory Pro" 试用版创建 S48
50 PPM PDF 文件以 "FinePrint pdffactory Pro" 试用版创建 S49
51 PPM PDF 文件以 "FinePrint pdffactory Pro" 试用版创建 S50
52 PPM PDF 文件以 "FinePrint pdffactory Pro" 试用版创建 S51
53 Bn Bn Bn S PPM S52
54 PPM PDF 文件以 "FinePrint pdffactory Pro" 试用版创建 S53
55 PPM PDF 文件以 "FinePrint pdffactory Pro" 试用版创建 S54
56 PPM PDF 文件以 "FinePrint pdffactory Pro" 试用版创建 S55
57 Bn Bn TBDPS Bz Bz S PPM S56
58 PPM PDF 文件以 "FinePrint pdffactory Pro" 试用版创建 S57
59 PPM PDF 文件以 "FinePrint pdffactory Pro" 试用版创建 S58
60 S59
61 PPM S60
62 S61
63 S62
64 S63
65 S64
66 S65
67 PPM S66
68 S67
69 PPM S68
70 S69
71 PPM S70
72 PPM S71
73 PPM PDF 文件以 "FinePrint pdffactory Pro" 试用版创建 S72
74 PPM S73
75 S74
76 PPM Bn Bn Bn Bn Bn Ac Bn Bn S75
77 S76
78 S77
79 S78
80 PPM S79
81 S80
82 S81
83 S82
84 PPM PDF 文件以 "FinePrint pdffactory Pro" 试用版创建 S83
85 S84
86 PPM S85
87 S86
88 PPM S87
89 PPM S88
90 PPM S89
91 PPM S90
92 S91
93 S92
94 S93
Table of Contents 1. General General procedure and product characterization data for Table ,3-Dione substrates characterization da
Supporting Information Wiley-VCH 2013 69451 Weinheim, Germany Highly Enantioselective Construction of 3-Hydroxy xindoles through a Decarboxylative Aldol Addition of Trifluoromethyl a-fluorinated gem-diols
More informationMicrosoft Word - Supporting Information clear
Supporting Information Galanthamine, Plicamine, and Secoplicamine Alkaloids from Zephyranthes candida and Their Anti-acetylcholinesterase and Anti-inflammatory Activities Guanqun Zhan, Junfei Zhou, Rong
More information1. General Information Unless otherwise noted, all reagents, catalysts and solvents were purchased from commercial suppliers and used without further
Supporting Information for Transformation of Alkynes into Chiral Alcohols via TfOH-Catalyzed Hydration and Ru-Catalyzed Tandem Asymmetric Hydrogenation Sensheng Liu, Huan Liu, Haifeng Zhou, *,, Qixing
More informationMicrosoft Word _File000004_ docx
Supporting Information The Discovery of 3,3 -spiro[azetidine]-2-oxo-indoline Derivatives as Fusion Inhibitors for Treatment of RSV Infection Weihua Shi 1, Zhigan Jiang 1, Haiying He 1 *, Fubiao Xiao 1,
More informationMicrosoft Word _File000001_ doc
Chemoselective N-Heterocyclic Carbene Catalyzed Cascade of Enals with Nitroalkenes Zijun Wu, Xu Wang, Fangyi Li, Jicheng Wu, Jian Wang* Department of Pharmacology and Pharmaceutical Sciences School of
More informationMicrosoft Word - Supporting information.doc
Enantioselective Organocatalytic Michael Addition of Malonates to α, β-unsaturated Ketones Pengfei Li, Shigang Wen, Feng Yu, Qiaoxia Liu, Wenjun Li, Yongcan Wang, Xinmiao Liang, * Jinxing Ye * Dalian Institute
More information标题
第 33 卷 第 6 期 钢 摇 铁 摇 钒 摇 钛 摇 摇 摇 摇 摇 摇 摇 摇 摇 摇 摇 2012 年 12 月 IRON STEEL VANADIUM TITANIUM 摇 摇 摇 摇 摇 摇 摇 摇 摇 摇 摇 摇 Vol 郾 33,No 郾 6 December 2012 氯 化 法 钛 白 生 产 装 置 三 废 处 理 工 艺 改 进 孙 洪 涛 ( 东 华 工 程 科 技 股 份
More informationMicrosoft Word - Electronic Supplementary Information.doc
Electronic Supplementary Material (ESI) for RSC Advances. This journal is The Royal Society of Chemistry 2015 Electronic Supplementary Information Natural Thioredoxin Reductase Inhibitors from Jatropha
More information[1] Nielsen [2]. Richardson [3] Baldock [4] 0.22 mm 0.32 mm Richardson Zaki. [5-6] mm [7] 1 mm. [8] [9] 5 mm 50 mm [10] [11] [12] -- 40% 50%
38 2 2016 4 -- 1,2, 100190, 100083 065007 -- 0.25 mm 2.0 mm d 10 = 0.044 mm 640 3 300. Richardson--Zaki,,, O359 A doi 10.6052/1000-0879-15-230 EXPERIMENTAL STUDY OF FLUID-SOLID TWO-PHASE FLOW IN A VERTICAL
More informationMolecules 2017, 22, 236; doi: /molecules S1 of S21 Supplementary Materials: Bioactive Stilbenes from Cortex Mori Radicis, and Their Neur
S1 of S21 Supplementary Materials: Bioactive Stilbenes from Cortex Mori Radicis, and Their Neuroprotective and Analgesic Activities Mediated by mglur1 Ya-Nan Wang, Mao-Feng Liu, Wei-Zhen Hou, Rui-Ming
More information2008 GUANGDONG WEILIANG YUANSU KEXUE : g/ d a : b : a/ b Ag As Au Cd Ce 1817
2008 GUANGDONG WEILIANG YUANSU KEXUE 15 2 : 1006 2 446X (2008) 02 2 00152 17. (, 201800) :,, ;, : ; ; ; ; : R 15313 : A, () () ( ) () () () [ 1 ],, 1,, ( ) 1996 1997, 4 ( ), 12 42 [ 2 ], (1) 1, 36, 17
More informationHyperascyrones A–H, Polyprenylated Spirocyclic Acylphloroglucinol Derivatives from Hypericum ascyron Linn
Electronic Supplementary Material (ESI) for rganic & Biomolecular Chemistry. This journal is The Royal Society of Chemistry 2018 Supplementary Material Anti-inflammatory fusicoccane-type diterpenoids from
More information<4D6963726F736F667420576F7264202D20B5DA39D5C220B4BCA1A2B7D3BACDC3D12E646F63>
第 9 章 醇 酚 醚 及 消 除 反 应 醇 酚 和 醚 都 是 烃 的 含 氧 衍 生 物 它 们 可 以 看 作 是 水 分 子 中 的 氢 原 子 被 烃 基 取 代 得 到 的 化 合 物 R Ar R R 水 醇 酚 醚 醇 和 酚 分 子 中 都 含 有 羟 基 (-), 酚 是 羟 基 直 接 与 苯 环 相 连 ; 醇 是 羟 基 与 脂 肪 族 碳 相 连 9.1 醇 9.1.1
More informationSVM OA 1 SVM MLP Tab 1 1 Drug feature data quantization table
38 2 2010 4 Journal of Fuzhou University Natural Science Vol 38 No 2 Apr 2010 1000-2243 2010 02-0213 - 06 MLP SVM 1 1 2 1 350108 2 350108 MIP SVM OA MLP - SVM TP391 72 A Research of dialectical classification
More informationMicrosoft Word - DGP.023.WP.007.CH.1102619.docx
国 际 民 用 航 空 组 织 工 作 文 件 DGP/23-WP/7 20/6/11 危 险 物 品 专 家 组 (DGP) 第 二 十 三 次 会 议 2011 年 10 月 111 日 至 21 日, 蒙 特 利 尔 议 程 项 目 2: 拟 定 对 危 险 物 品 安 全 航 空 运 输 技 术 细 则 (Doc 9284 号 文 件 ) 的 修 订 建 议, 以 便 纳 入 2013 年
More informationuntitled
理 料 易 行 年 年 類 了 料 料 易 理 不 理 率 異 數 量 率 料 量 ~ ~ ~ 料 量 1 料 年 陸 不 料 年來 類 量 年 類 量 類 量 類 量 量不 量不 量不 蘭 量不 年 令 量 類 量 量 年來 力 量 降 量 料 類 年來 類 料 量 量 了 立 類 量 料 量 率 率 度 留 率 率 度 理 不 例行 立了 易 量 料 量 行 立 易 量 例行 2 料 料 料 (distilled
More information第六章 醇、酚、醚\(Alcohols、Phenols、Ethers\)
Ethers) (Alcohols Phenols 6.1 1. 1) CH 2 H CH 2 H CH 2 H CH H CH 2 H CH 2 H 2) CH 2 H H CH 2 CH CH 2 H 3) 2. 1- 1-6- -2-5- -3- 4-(2- -2- 4- - -1- 3. 1) (1) (2) ( ) 2 C CH 2 1) H 2 S 4 2) H
More information! "#$%& $()*+#$, $(-.&,./.+#/(-.&01( &-#&(&$# (&2*(,#-3.,14& $ +()5(*-#5(-#/-/#(-1#&-+)(& :;<<= > A B?
! "#$%& $()*+#$, $(-.&,./.+#/(-.&01( &-#&(&$# (&2*(,#-3.,14& $ +()5(*-#5(-#/-/#(-1#&-+)(&- 67789:;
More information岛津LC应用系统
Access to your success SHIMADZU Access to your success SHIMADZU Access to your success SHIMADZU Access to your success SHIMADZU Co-Sense for BA Co-Sense for BA + LCMS Access to your success SHIMADZU Access
More information中 文 摘 要 芦 荟 和 金 银 花 抗 菌 成 分 提 取 及 其 对 棉 织 物 的 整 理 中 文 摘 要 随 着 生 活 水 平 的 提 高 和 健 康 环 保 意 识 的 增 强, 人 们 对 棉 织 物 卫 生 保 健 功 能 的 要 求 越 来 越 高, 故 对 棉 织 物 进 行
高 等 学 校 教 师 硕 士 学 位 论 文 (2008 届 ) 芦 荟 和 金 银 花 抗 菌 成 分 提 取 及 其 对 棉 织 物 的 整 理 Extraction of Aloe and Honey Suckle Antibacterial Ingredients and Application to Antibiotic Finishing of Cotton 研 究 生 姓 名 指 导
More information标题
第 33 卷 第 6 期 钢 摇 铁 摇 钒 摇 钛 摇 摇 摇 摇 摇 摇 摇 摇 摇 摇 摇 2012 年 12 月 IRON STEEL VANADIUM TITANIUM 摇 摇 摇 摇 摇 摇 摇 摇 摇 摇 摇 摇 Vol 郾 33,No 郾 6 December 2012 配 碳 比 对 TiO 2 真 空 碳 热 还 原 的 影 响 周 玉 昌 ( 攀 钢 集 团 研 究 院 有 限
More information对 乙 酰 氨 基 酚 片 片 剂 500mg 12 片 盒 铝 塑 泡 罩 - 华 润 双 鹤 药 业 股 份 有 限 公 司 华 润 双 鹤 药 业 股 份 有 限 公 司 全 市 沪 药 事 药 品 (2012)110 号 对 乙 酰 氨 基 酚 片 片 剂 500mg 12 片 盒 铝 塑
上 海 市 医 疗 机 构 基 本 药 物 集 中 招 标 采 购 中 标 目 录 ( 第 一 批 ) 注 释 : 1 全 市 指 全 市 各 级 各 类 医 疗 机 构 ; 2 非 基 层 指 除 基 层 医 疗 卫 生 机 构 以 外 的 其 他 各 级 各 类 医 疗 机 构 药 品 通 用 名 商 品 名 剂 型 规 格 包 装 单 位 包 装 方 式 中 标 价 ( 元 ) 中 标 企 业
More informationMicrosoft Word - 4期中文目次.doc
中 草 药 Chinese Traditional and Herbal Drugs 第 45 卷 第 4 期 2014 年 2 月 509 UPLC-MS/MS 法 快 速 检 测 减 肥 类 保 健 品 中 13 种 非 法 添 加 化 学 成 分 朱 健, 裘 一 婧, 沈 国 芳 杭 州 市 食 品 药 品 检 验 研 究 院, 浙 江 杭 州 310017 摘 要 : 目 的 建 立 保
More informationMicrosoft Word - 2014版天然药物化学复习题.doc
天 然 药 物 化 学 复 习 题 河 北 医 科 大 学 药 学 院 天 然 药 物 化 学 教 研 室 2014 年 2 月 整 理 一 名 词 解 释 1. 有 效 成 分 和 无 效 成 分 2. 1-1 CSY 3. R-MS 4. MBC 5. MQC 6. 苷 苷 键 苷 键 原 子 7. 苷 化 位 移 8. 黄 酮 类 化 合 物 9. 经 验 的 异 戊 二 烯 规 则 10.
More information基 礎 化 學 ( 一 ) 講 義 目 次 第 1 章 物 質 的 組 成 1 1 物 質 的 分 類 1 1 2 原 子 與 分 子 16 1 3 原 子 量 與 分 子 量 31 1 4 溶 液 48 實 驗 二 硝 酸 鉀 的 溶 解 與 結 晶 74 國 戰 大 考 試 題 78 實 驗 相
內 容 由 蔡 明 倫 老 師 和 李 雅 婷 老 師 編 纂 基 礎 化 學 ( 一 ) 講 義 第 1 章 物 質 的 組 成 班 級 : 拉 瓦 節 和 其 使 用 的 實 驗 儀 器 座 號 : 姓 名 : 基 礎 化 學 ( 一 ) 講 義 目 次 第 1 章 物 質 的 組 成 1 1 物 質 的 分 類 1 1 2 原 子 與 分 子 16 1 3 原 子 量 與 分 子 量 31 1
More information材 料 与 方 法 仪 器 ACQUITY UPLC Xevo TQ-S 三 重 四 级 杆 液 质 联 用 仪 ( 美 国 Waters 公 司 ); 电 喷 雾 离 子 源 (ESI), Masslynx 4.1 数 据 处 理 系 统 (Waters);Thermo 低 温 离 心 机 ;KQ
[ 应 用 纪 要 ] Rapid identification of 5 illegal additives in slimming health food by Xevo TQ-S 郝 刚 苏 州 市 食 品 药 品 检 验 所, 苏 州 15104 关 键 词 超 高 效 液 相 色 谱 - 质 谱, 多 反 应 监 测, 减 肥 类 保 健 食 品 非 法 添 加, 快 速 定 性 定 量
More information<4D F736F F D20B5DA3133D5C220B0B7A1A2D6D8B5AABACDC5BCB5AABBAFBACFCEEF2E646F63>
第 13 章 胺 重 氮 和 偶 氮 化 合 物 胺 (amines) 是 最 重 要 的 含 氮 化 合 物, 它 可 看 作 是 氨 的 烃 基 取 代 物, 根 据 氮 上 烃 基 取 代 的 数 目, 可 将 胺 分 为 伯 ( 一 级 ) 胺 仲 ( 二 级 ) 胺 叔 ( 三 级 ) 胺 和 季 ( 四 级 ) 铵 盐 : 3 R R 2 R 3 R 4 + X - 氨 伯 胺 仲 胺
More informationWATER PURIFICATION TECHNOLOGY April 5th, 0.4 TiO TiO UV-0PC UNICO [0] TiO TiO TiO HNO 00 W TiO TiO TiO >40 nm TiO 0 ml 0 mg / L -. TiO 6 ml 40 ml 60 m
0 0 50-54 Water Vol. Purification 0, No. Technology, 0,,. 50090. 0040 TiO TiO TiO + [] + + TiO TiO TiO TiO TiO TiO TiO TiO TU99 B 009-077 0 0-0050-05 Degradation of Methyl Orange with Metal Ion Modified
More informationTable of Contents
Electronic Supplementary Material (ESI) for Catalysis Science & Technology. This journal is The Royal Society of Chemistry 205 Supporting Information Novel glycosyl pyridyl-triazole@palladium nanoparticles:
More information1 y ml / h kg x mg /d y 2. 5 ml / h kg 0. 3 ml / h kg y = 0. 143 + 0. 046 x r = 0. 994 7 10 PAVELKA 2 Wistar 5 Br - Cl - HCO3 - ClO - 4 SCN - 14 d 82
1006-446X 2011 10-0001-021 1 2 1. 201800 2. 201800 2001 2010 80% 8 5 O 613. 43 R 969 A 1857 1912 1980 20 1 1. 1 SOREMARK 1960 12 d 1 SANGSTER 1983 10 d MAY 1992 8 ~ 14 d 6 ~ 8 d RAUWS 1975 91 mg /kg 3
More information绪论 疾病概论
新 疆 医 科 大 学 教 案 首 页 编 号 :02 课 程 名 称 病 理 生 理 学 专 业 临 床 医 学 口 腔 医 学 基 础 医 学 医 学 影 像 麻 醉 医 学 医 学 检 验 临 床 药 学 专 业 层 次 本 硕 和 本 科 主 讲 老 师 克 拉 拉 阿 巴 斯 计 划 时 数 3 班 级 2010 级 各 班 专 业 技 术 职 称 病 理 生 理 学 教 授 编 写 时
More information第十一章 颈部疾病病人的护理
第 十 一 章 颈 部 疾 病 病 人 的 护 理 学 习 目 标 1. 了 解 颈 部 常 见 肿 块 病 人 的 身 体 状 况 及 处 理 原 则 ; 能 提 出 甲 状 腺 肿 瘤 甲 状 腺 功 能 亢 进 病 人 的 护 理 诊 断 并 制 定 出 护 理 措 施 2. 熟 悉 甲 状 腺 肿 瘤 甲 状 腺 功 能 亢 进 病 人 的 身 体 状 况 手 术 适 应 证 3. 掌 握
More informations 15 contact s W Si 3 N μm N / m 4 AFM 95% AFM WPOJ UPOJ WPOJ UPOJ 260 ~ 280 nm WPOJ-DS UPOJ-DS 1 cm 1 cm DEAE-ce
32 1 2013 2 Journal of Chinese Electron Microscopy Society Vol. 32 No. 1 2013-02 1000-6281 2013 01-0054-08 1 1* 2 1 1 1. 2. 710062 AFM SEM WPOJ-DS UPOJ-DS WPOJ-DS β- UPOJ-DS AFM WPOJ-DS UPOJ-DS SEM UPOJ-DS
More information, GC/MS ph GC/MS I
S00017052 O O , GC/MS ph GC/MS I Abstract Drug abuse is a serious issue throughout the world. Amphetamine-type stimulants (ATS) are substances frequently used by drug abusers. There are significant needs
More informationMicrosoft Word _editing
我 国 冷 冻 鱼 糜 生 产 及 标 准 现 状 分 析 顾 晓 慧 1,2, 殷 邦 忠 2, 王 联 珠 2,*, 朱 文 嘉 2, 郭 莹 莹 2 (1. 中 国 海 洋 大 学 食 品 科 学 与 工 程 学 院, 山 东 青 岛 266003;2. 中 国 水 产 科 学 研 究 院 黄 海 水 产 研 究 所, 山 东 青 岛 266071) 摘 要 : 冷 冻 鱼 糜 是 高 附 加
More informationH 2 SO ml ml 1. 0 ml C 4. 0 ml - 30 min 490 nm 0 ~ 100 μg /ml Zhao = VρN 100% 1 m V ml ρ g
16 6 2018 11 Chinese Journal of Bioprocess Engineering Vol. 16 No. 6 Nov. 2018 doi 10. 3969 /j. issn. 1672-3678. 2018. 06. 004 1 2 1 1 1. 330200 2. 330006 4 Box-Behnken 1 25 g /ml 121 92 min 2 6. 284%
More information中国帝王私生活未解之谜(二).doc
() ...1...5...14...19...29...38...45...53...63...69...77...85...98... 107... 112... 120... 131... 142... 151 I ... 161... 171... 177... 186... 194 II 1 2 3 214 4 (182 252 ) 229 252 5 6 ( ) (208 ) (229
More informationuntitled
1-1 1-2 1-3 1-4 1-5 1-6 1-7 1-8 1-9 SI SI 1-1 (science) (chemistry) (observation)(evaluation) (experimentation) (description) (hypothesis) 1. 2. 3. (phase)(solid phase) (liquid phase)(phase change) (information)(data)
More information1 065007 2 065007 3 065007 Discussion about Natural Gas Hydrate Formation Conditions and Accumulation Pattern in China s Major Permafrost Regions Zhang Jinhua 1,2, Wei Wei 1,2, Wei Xinghua 1, Wang Yuanyuan
More information10 生物有机化合物
9 元 素 有 机 化 合 物 内 容 提 要 本 章 在 学 习 了 含 碳 氢 氧 氮 卤 素 等 元 素 的 有 机 化 合 物 的 基 础 上, 重 点 学 习 有 机 铜 有 机 钯 有 机 铁 等 金 属 元 素 有 机 化 合 物 ; 学 习 有 机 硫 有 机 磷 有 机 硅 等 非 金 属 元 素 有 机 化 合 物, 比 较 相 对 应 的 含 氧 化 合 物 含 氮 化 合 物
More information第一类
第 一 类 用 于 工 业 科 学 摄 影 农 业 园 艺 森 林 的 化 学 品, 未 加 工 人 造 合 成 树 脂. 未 加 工 塑 料 物 质, 肥 料. 灭 火 用 合 成 物, 淬 火 和 金 属 焊 接 用 制 荆. 保 存 食 品 用 化 学 品, 鞣 料, 工 业 用 粘 合 剂 注 释 本 类 主 要 包 括 用 于 工 业 科 学 和 农 业 的 化 学 制 品, 包 括 制
More information标题
648 江 苏 农 业 学 报 (Jiangsu J. of Agr. Sci. ),2013,29(3):648 ~ 653 h ttp: / / w w w. jsn y x b.c o m 王 摇 丹, 孙 摇 蕾, 孙 家 正, 等. 桑 葚 冻 结 过 程 中 的 温 度 变 化 特 性 [J]. 江 苏 农 业 学 报,2013,29(3):648 鄄 653. doi:10. 3969
More information382 25,,, 4.2 g 96% m.p.139~140 ( [21] :138~139 ), (4- )-2,2 6,2 - (L), [17], 2.5 mmol 1-(2- )-, 2.5 mmol 1-(2- )-(4- ) -1-2,2 6,2 (25.0 mmol),
25 3 2009 3 CHINESE JOURNAL OF INORGANIC CHEMISTRY Vol.25 No.3 381~385 4-1 *,1 1 1,2 ( 1, 361005) ( 2, 361005) : -2,2 6,2 -,4 - -2,2 6,2 - (L), L (ZnL),, ZnL 1 1 2 1 2 1,ZnL : ; 4 - -2,2 6,2 - ; ; : O614.24
More information1 2-14 I + A + 1 2 2 I 8 5 14 7 5 14 2 3 Ε K = RT ZF + K ln [ ] + [ K ] 0 i ( mv) + K Ε K = 595. lg [ ] 0 ( mv) + [ K ] i 60% 40% 20% 15% 4% 1% 55
More informationMicrosoft Word - 120333.doc
有 机 化 学 DI: 10.6023/cjoc1108081 Chinese Journal of rganic Chemistry 新 型 一 枝 蒿 酮 酸 异 噁 唑 衍 生 物 的 合 成 及 其 抗 A, B 型 流 感 病 毒 活 性 研 究 赵 江 瑜 a,b 阿 吉 艾 克 拜 尔 艾 萨 *,a ( a 中 国 科 学 院 新 疆 理 化 技 术 研 究 所 干 旱 区 植 物
More information权 利 要 求 书 1/1 页 1. 一 种 草 莓 贮 藏 保 鲜 方 法, 其 特 征 在 于, 包 括 以 下 步 骤 : a 采 收 八 至 九 成 熟 草 莓, 挑 选 大 小 均 一 无 病 虫 害 机 械 损 伤 的 草 莓 ; b 将 草 莓 置 于 保 鲜 剂 中 浸 泡 5 ~
(19) 中 华 人 民 共 和 国 国 家 知 识 产 权 局 (12) 发 明 专 利 申 请 (21) 申 请 号 201310405033.X (10) 申 请 公 布 号 CN 103478239 A (43) 申 请 公 布 日 2014.01.01 (22) 申 请 日 2013.09.06 (71) 申 请 人 中 国 科 学 院 华 南 植 物 园 地 址 510650 广 东 省
More information1 引言
P P 第 40 卷 Vol.40 第 7 期 No.7 计 算 机 工 程 Computer Engineering 014 年 7 月 July 014 开 发 研 究 与 工 程 应 用 文 章 编 号 :1000-348(014)07-081-05 文 献 标 识 码 :A 中 图 分 类 号 :TP391.41 摘 基 于 图 像 识 别 的 震 象 云 地 震 预 测 方 法 谢 庭,
More information4.1 液 相 色 谱 - 三 重 四 极 杆 质 谱 联 用 仪 4.2 天 平 4.3 超 声 波 清 洗 仪 4.4 离 心 机 4.5 涡 旋 混 合 仪 5 分 析 步 骤 5.1 标 准 系 列 溶 液 的 制 备 分 别 精 密 吸 取 10.0 µg/ml 的 标 准 工 作 溶 液
附 件 1 化 妆 品 中 丙 烯 酰 胺 的 检 测 方 法 ( 征 求 意 见 稿 ) 1 范 围 本 方 法 规 定 了 化 妆 品 中 丙 烯 酰 胺 的 液 相 色 谱 - 串 联 质 谱 测 定 方 法 本 方 法 适 用 于 液 态 水 基 类 液 态 油 基 类 凝 胶 类 膏 霜 乳 液 类 粉 类 化 妆 品 中 丙 烯 酰 胺 的 测 定 2 方 法 提 要 样 品 提 取 净
More information1 GIS 95 Y = F y + (1 F) (1) 0 0 Y0 kg/hm 2 /day F y 0 y c kg/hm 2 /day [12] y m 20 kg/hm 2 /hour Y = cl cn ch G [ F( y ) T m yo + (2) (1 F)(
24 1 Vol.24 No.1 94 2008 1 Transactions of the CSAE Jan. 2008 2008 1 100094 2 100035 3 100081 4 100081 5 100101 GIS ( ) 65.12 16.82 13.74 15.27 11.07 t/(hm 2 a) 10.93% 41.43% 46.93% 65.4%. Bi Jiye, Zhu
More informationMicrosoft Word - JACS_SI-3 R2 _NMR spectra-II_.docx
Supporting Information III Efficient Convergent Synthesis of Bi-, Tri-, and Tetraantennary Complex Type N-Glycans and Their HIV-1 Antigenicity Sachin S Shivatare,,, Shih-Huang Chang,, Tsung-I Tsai, Chien-Tai
More information5月第11期
中 国 农 学 通 报 0,():-9 hinese gricultural Science ulletin 番 石 榴 风 味 果 糕 的 加 工 研 究, 郑 毅, 伍 斌,, 邓 建 梅, 康 瑛 瑜 ( 攀 枝 花 学 院 生 物 与 化 学 工 程 学 院, 四 川 攀 枝 花 000; 攀 枝 花 市 干 热 河 谷 特 色 生 物 资 源 工 程 技 术 中 心, 四 川 攀 枝 花
More informationMicrosoft Word - 20101483毕业论文+-+副本
密 级 : 公 开 学 号 :20101483 硕 士 学 位 论 文 祛 斑 玉 容 方 对 色 素 沉 着 小 鼠 血 酪 氨 酸 酶 及 皮 肤 形 态 的 影 响 研 究 生 王 茜 指 导 教 师 学 科 专 业 所 在 学 院 毕 业 时 间 孙 亦 农 中 医 康 复 学 第 二 临 床 医 学 院 2013 年 6 月 Freckle of Yurong side of pigmentation
More information+ 7 1 5, Cl Cl + 4 + 6 HSO4 S S S + 6 + 6 HSO4 S S S 0 + 6 + 4 + S S S S + 7 + KMnO 4 Mn Mn + + + [I ] 0 1M 0 I E Fe3+ / Fe+ ( 0771. ) E 1 /1 ( 0536. ) 3+ 3+ + 3+ Fe I I Fe + I = Fe + I [ Fe ] = [ I ]
More information中华人民共和国国家环境保护标准
中 华 人 民 共 和 国 国 家 环 境 保 护 标 准 HJ 809-2016 水 质 亚 硝 胺 类 化 合 物 的 测 定 气 相 色 谱 法 Water quality-determination of nitrosamine compounds Gas chromatography ( 发 布 稿 ) 本 电 子 版 为 发 布 稿 请 以 中 国 环 境 科 学 出 版 社 出 版 的
More information避孕篇
避 孕 篇 生 育 后 时 期 的 避 孕 方 法 : 适 用 的 方 法 : 1) 宫 内 节 育 器 类 : 金 属 环 可 放 置 15 年 左 右 ;V 型 环 可 放 置 5-7 年 ;T 型 环 可 放 置 10-15 年 2) 避 孕 药 ( 针 ) 类 : 各 种 短 效 口 服 避 孕 药, 如 妈 富 隆 敏 定 偶 三 相 片 及 达 英 -35 等, 按 规 定 方 法 服
More information240 生 异 性 相 吸 的 异 性 效 应 [6] 虽 然, 心 理 学 基 础 研 [7-8] 究 已 经 证 实 存 在 异 性 相 吸 异 性 相 吸 是 否 存 在 于 名 字 认 知 识 别 尚 无 报 道 本 实 验 选 取 不 同 性 别 的 名 字 作 为 刺 激 材 料, 通
2011 年 Journal of Capital Medical University 4月 第2 期 Apr 2011 Vol 32 No 2 基础研究 doi: 10 3969 / j issn 1006-7795 2011 02 015 人脑识别不同性别名字反应时的差异研究 高迎霄 陈昭燃 * 张明霞 ( 首都医科大学神经生物系高级脑功能中心) 摘要 目的 探讨男女对不同性别名字认知加工速度是否存在差异
More information9.1.乳房炎
1. 1 3 4 5 -- -- 1 3 2 3,, 3 4 2. : 1 2 3 4 6~12h 2 1~2d (1) 15~18 7~15b 70% 2%~5% 2 3 2. 1 2 3. 3-7d 3-4 ( ) 1 2 3% 2 3 2% 1% 2 3 3 5 10mg 10% 4. (1) (2) (3) (4) (5) (1) (2) 3
More information14-0390-0696.doc
390 药 学 学 报 Acta Pharmaceutica Sinica 2013, 48 (3): 390 394 HPLC-MS/MS 法 定 量 研 究 比 格 犬 灌 胃 替 诺 福 韦 酯 后 替 诺 福 韦 血 浆 药 代 动 力 学 * 王 宝 莲, 扈 金 萍, 盛 莉, 陈 晖, 李 燕 ( 中 国 医 学 科 学 院 北 京 协 和 医 学 院 药 物 研 究 所, 北 京 100050)
More information01-0982.doc
第 32 卷 第 7 期 岩 土 工 程 学 报 Vol.32 No.7 2010 年 7 月 Chinese Journal of Geotechnical Engineering July 2010 沿 海 碎 石 回 填 地 基 上 高 能 级 强 夯 系 列 试 验 对 比 研 究 年 廷 凯 1,2, 水 伟 厚 3, 李 鸿 江 4, 杨 庆 1,2, 王 玉 立 (1. 大 连 理 工
More information114 () ml,60 2 g 20 ml, 120 r/ min,12. 3,, 3, ( Fluroscein diacetate, FDA). 2 mg FDA 1 ml, 50,0. 04 g/ L. FDA 1 1, 10 min,,., = / 100
48 1 () Vol. 48 No. 1 2009 1 Journal of Xiamen University (Nat ural Science) Jan. 2009 1, 1 3, 2 (1.,, 361005 ; 2., 730000) :, (DMSO). :DMSO,. 75 mmol/ L DMSO 48 h,, 1. 6 1. 8 ;10mol/ L 48 h,,;,. : ; ;
More information试题二
试 题 二 一 解 释 名 词 ( 每 题 2 分, 计 10 分 ) 1. 胎 膜 早 破 2. 产 后 出 血 3. 胎 方 位 4. 第 二 产 程 5. 前 置 胎 盘 二 填 空 题 ( 每 空 0.5 分, 计 10 分 ) 1. 人 工 流 产 术 常 见 的 并 发 症 有 2. 青 春 期 功 血 的 治 疗 原 则 是 3. 胎 心 的 正 常 值 是 次 /min 4. 子 宫
More information[1-3] (Smile) [4] 808 nm (CW) W 1 50% 1 W 1 W Fig.1 Thermal design of semiconductor laser vertical stack ; Ansys 20 bar ; bar 2 25 Fig
40 6 2011 6 Vol.40 No.6 Infrared and Laser Engineering Jun. 2011 808 nm 2000 W 1 1 1 1 2 2 2 2 2 12 (1. 710119 2. 710119) : bar 808 nm bar 100 W 808 nm 20 bar 2 000 W bar LIV bar 808 nm : : TN248.4 TN365
More informationuntitled
Agilent ZORBAX Agilent ZORBAX HPLC... phzorbax 3 1. 6-9 2. www.agilent.com/chem/lccolumntips 3. 800-820-3278 ...2 ZORBAX...5........................................................................ 6 ZORBAX..................................................................
More informationPCA+LDA 14 1 PEN mL mL mL 16 DJX-AB DJ X AB DJ2 -YS % PEN
21 11 2011 11 COMPUTER TECHNOLOGY AND DEVELOPMENT Vol. 21 No. 11 Nov. 2011 510006 PEN3 5 PCA + PCA+LDA 5 5 100% TP301 A 1673-629X 2011 11-0177-05 Application of Electronic Nose in Discrimination of Different
More information1 MCF-7 VEGF spss 20 5 ~ 6 h Cck-8 6 h r 2 = Cck-8 6 h 450 nm v Cck-8 v = h 450 nm 3 A = A - A A r 2 Cck -8 Mcf-7 1
42 1 Vol 42 No 1 2018 1 Journal of Jiangxi Normal University Natural Science Jan 2018 1000-5862 2018 01-0100-06 MCF-7 VEGF 1 2 1 1 1 1* 1 570228 2 70102 Mcf -7 Cck-8 TUNEL- DAPI Cck-8 Cck-8 TUNEL-DAPI
More informations 2002
s 2002 List of all Catalogs from Electrical Installation Technology (ET) Electrical Installation Catalogs Technology ( / ) Miniature Circuit-Breakers, Residual Current Operated Circuit- Breakers and Modular
More informationGB Sparkle
GB 24613-2009 Chinese Mandatory Standard for Toy Coatings With growth of the toy industry and improvement of toys quality, the China National Paints and Pigments Standardization Technical Committee introduced
More informationPowerPoint Presentation
朱 传 娴 高 校 客 户 顾 问 hzhu@acsi.info SciFinder 最 新 发 展 及 使 用 反 馈 交 流 ----14 th DRAA 培 训 周 SciFinder 用 户 座 谈 会 提 纲 美 国 化 学 文 摘 社 简 介 SciFinder 简 介 及 在 学 科 服 务 中 的 应 用 SciFinder 最 新 发 展 --PatentPak 简 介 --MethodsNow
More information2004级研究生现代免疫学实验技术结业报告
PCR PCR PCR RT-PCR PCR (Polymerase Chain Reaction,PCR) 80 DNA, DNA PCR PCR PCR DNA PCR -- -- DNA DNA 93 DNA PCR DNA DNA ( ) DNA 55 DNA DNA -- TaqDNA dntp DNA -- -- PCR PCR DNA DNA Y (1 X) n Y DNA X (Y)
More informationuntitled
ESS/ ESV ESS/ ESV ESH 1) Vulkollan /Internet ESS- -S 2, 4 3mm 2) 1 6, 8 4mm 2) 2 10, 15 M4 3 20, 30, 40, 50 M6 4 60, 80, 100 M10 5 150, 200 M20x2 6 ESS- -E 15 M4 3 10 20, 30, 40, 50 M6 4 60, 80, 100 M10
More information<BBF9B4A1CDB3BCC628B5DACBC4B0E629CFB0CCE2BCAF2E6D7073>
第 三 章 统 计 整 理 复 习 提 要 本 章 介 绍 了 统 计 整 理 在 统 计 活 动 中 的 作 用, 统 计 整 理 的 内 容 和 统 计 资 料 审 核 与 汇 总 的 技 术, 重 点 阐 述 了 统 计 分 组 的 理 论 与 方 法 变 量 数 列 的 编 制 统 计 表 的 构 成 和 制 表 规 范, 简 要 介 绍 了 统 计 图 的 基 本 内 容 复 习 中 要
More information㈠ 1. (Olympus BX51) (Evolution/QImaging Digital Camera kit) 2. ( G A E R r o t a r y microtome) 3. (Forma Scientific 6512 Vaccum Oven)
. 1 : 289-298 2010 Ann. Rept. Food Drug Res. 1 : 289-298 2010 289 (Panax ginseng C. A. Meyer) (Panax quinquefolium L.) 46 47 PCR-DNA 46 23 9 (39%) 24 2 (8%)47 77% 23 Acquity BEH C 18 2.1 mm 100 mm 1.7
More information9期
中 国 农 学 通 报 04,0(9):0-4 Chinese Agricultural Science Bulletin 柚 子 红 枣 酸 奶 的 发 酵 工 艺 研 究 邵 金 华, 余 响 华, 晏 资 忠, 朱 智 勇 ( 湖 南 科 技 学 院, 湖 南 永 州 499) 摘 要 : 以 柚 子 汁 红 枣 汁 和 脱 脂 奶 粉 为 主 要 原 料, 以 保 加 利 亚 乳 杆 菌 和
More informationactivities than commercial antibacterial agents. Moreover, "Extract Cleanser was safe to organisms as the result of toxicity evaluation identified by
Journal of China Institute of Technology Vol.32-2005.5 Assessment of Property and Function of All-Purpose Natural Anti-Bacteria Cleanser 1 2 3 * Li-chun Wu Ying-chien Chung Sheng-shih Chang 1 2 3 ( ) (APEO)
More informationuntitled
, ( ),,, ( ) :, ( ) ( ) : : : ( ) : : : 2 2 1 : : ,,,,,,,,,,,,,,,,,,,, ;,,, 6,,,,,,,,,,,,,,,,, 8 ( ) 2 3 4 5 6 ( ) 7 8 9 ,,,,, 1, ( ),,,,,,,,,,,,,, 3 t,,, ;,,,,,,,, t, 3,, 8 t,,,,, : (1 ),,, ; (2 ),,,,,
More informationMicrosoft Word - 20-罗方方-冯_new_.doc
第 36 卷 第 4 期 渔 业 科 学 进 展 Vol.36, No.4 2015 年 8 月 PROGRESS IN FISHERY SCIENCES Aug., 2015 DOI: 10.11758/yykxjz.20150420 http://www.yykxjz.cn/ 气 相 色 谱 - 质 谱 法 测 定 渔 业 水 质 中 * 8 种 除 草 剂 的 残 留 量 1 罗 方 方 王
More information296 FINE CHEMICALS 33 Sinensis Lam extracts = system systemⅢ performed best. Key words natural surfacetant Camellia Oleifera Abel meal Sap
3 3 3 2 0 1 6 3 FINE CHEMICALS Vol. 3 3 No. 3 Mar. 2 0 1 6 610041 Camellia Oleifera Abel meal Sapindus Mukorossi Gaertn Gleditsia Sinensis Lam Sanherb Rosen m m = 1. 58 1. 00 Ⅲ 76% m m = 1. 90 1. 00 Ⅱ
More informationMicrosoft Word - 3098-3102 20150611007-蔡伟江-二校
6 8 Vol. 6 No. 8 2015 8 Journal of Food Safety and Quality Aug., 2015 蔡 伟 江 *, 邓 鹏 飞, 刘 光 兰, 李 丹 (, 519040) 摘 要 : 目 的, 方 法 (4.6 mm 250 mm, 5.0 μm) ; : : : =70: 16: 14(V:V:V),, : 1.0 ml/min; : 40 ; : 10
More informationuntitled
709 δ δ 20 30, IPN [1~5] / [6~9 ] [ 6~8] / / CPE ACM [6,8 ] NBR A-80 A-60 CPE NBR CN NBR 710 NBR/ / 1 1.1 N220S JSR 41%( ) A-80 Asahi Denka Industries Co. A-60 1010 1 A-80 A-60 122.5 126 A-80 A-60 40.9
More informationPumps for Desalination Plants in Chinese
145 2 Product Types End Suction Pumps Axial Split Pumps Multistage Pumps Vertical Pumps Pump Type Water Intake Filter Feed/ LP Booster HP Feed HP Booster Filter Backwash Chemical Cleaning Product Transfer
More information酸檸檬?鹼檸檬??食物的酸鹼性.doc
篇 名 : 酸 檸 檬? 鹼 檸 檬? 食 物 的 酸 鹼 性 作 者 : 何 國 維 國 立 埔 里 高 工 化 工 科 二 年 乙 班 指 導 老 師 : 余 志 輝 老 師 壹 前 言 食 物, 是 人 類 每 天 的 能 量 的 來 源, 無 論 酸 甜 苦 辣, 各 式 各 樣 的 食 物 隨 處 可 見, 頗 具 豐 富 性 及 變 化 性, 令 人 食 指 大 動 但 是, 日 前 科
More informationP3 膠體電泳法
Polyacrylamide Gel Electrophoresis 聚 丙 烯 醯 胺 膠 体 電 泳 莊 榮 輝 3.1 電 泳 原 理 帶 電 分 子 在 電 場 中 能 夠 移 動, 稱 作 泳 動, 泳 動 的 程 度 稱 為 泳 動 率 (mobility).. 泳 動 率 ~ ( 所 外 加 電 壓 mv) ( 分 子 之 淨 電 荷 ) 分 子 與 介 質 間 之 摩 擦 力 上 述
More information2 ( 自 然 科 学 版 ) 第 20 卷 波 ). 这 种 压 缩 波 空 气 必 然 有 一 部 分 要 绕 流 到 车 身 两 端 的 环 状 空 间 中, 形 成 与 列 车 运 行 方 向 相 反 的 空 气 流 动. 在 列 车 尾 部, 会 产 生 低 于 大 气 压 的 空 气 流
第 20 卷 第 3 期 2014 年 6 月 ( 自 然 科 学 版 ) JOURNAL OF SHANGHAI UNIVERSITY (NATURAL SCIENCE) Vol. 20 No. 3 June 2014 DOI: 10.3969/j.issn.1007-2861.2013.07.031 基 于 FLUENT 测 轨 道 交 通 隧 道 中 电 波 折 射 率 结 构 常 数 张 永
More information最新执法工作手册(九十八)
..................... I ...................................... II ............................... III ' ' 24 9 11 [2000]25 12 2001 1 20 ?br>
More information30期
中 国 农 学 通 报 2014,30(30):285-289 Chinese Agricultural Science Bulletin 傅 里 叶 变 换 红 外 光 谱 法 在 橄 榄 油 掺 假 鉴 别 中 的 应 用 黄 秀 丽, 黄 飞, 曾 宪 远, 宁 焕 焱, 唐 丽 娜, 奉 夏 平 ( 广 东 省 惠 州 市 质 量 计 量 监 督 检 测 所, 广 东 惠 州 516003)
More information第十六章绿色有机合成
18 1 1811 1812 1813 182 1821 1822 1823 183 1831 1832 1833 1834 1835 184 1841 1842 1843 1844 1845 185 1851 1852 1853 1854 1855 1856 1857 20, 20 20 70 18 2 Environmentally BenignChemistry)(Environmentally
More informationé SI 12g C = 6 12 = 1 H2( g) + O2( g) H2O( l) + 286kJ ( 1) 2 1 1 H 2( g) + O2( g) H2O( l) H = 286kJ mol ( 2) 2 1 N 2 ( g) + O2( g) NO 2 ( g) 34kJ 2 1 1 N 2 ( g) + O2( g) NO 2 ( g) H = + 34kJ mol 2 1 N
More information%
38 1 2014 1 Vol. 38No. 1 January 2014 51 Population Research 2010 2010 2010 65 100028 Changing Lineal Families with Three Generations An Analysis of the 2010 Census Data Wang Yuesheng Abstract In contemporary
More information200 31 5 SWAN 0. 01 0. 01 6 min TITAN Thunder Identification Tracking Analysis SWAN TITAN and Nowcasting 19 TREC Tracking Radar Echo by Correlaction T
31 1 2013 3 Journal of Arid Meteorology Vol. 31 No. 1 March 2013. SWAN J. 2013 31 1 199-205. doi 10. 11755 /j. issn. 1006-7639 2013-01 - 0199 SWAN 730020 2011 7 7 SWAN SWAN 2012 2 SWAN 1006-7639 2013-01
More information32期
中 国 农 学 通 报 2014,30(32):38-42 Chinese Agricultural Science Bulletin 中 草 药 饲 料 添 加 剂 对 黄 鳝 性 激 素 含 量 的 影 响 1,2 1,2 1,2 2 赵 庆 凯, 丁 炜 东, 邴 旭 文, 王 建 新 ( 1 南 京 农 业 大 学 无 锡 渔 业 学 院, 江 苏 无 锡 214081; 2 中 国 水 产
More information2011 GUANGDONG WEILIANG YUANSU KEXUE 18 12 1. 1. 2 500 730 2 5 1 1 1. 1. 3 739 127 116 712 265 3 143 50 2 2 1 13 2 14 3 15 4 16 5 17 6 18 7 19 8 20 9
2011 GUANGDONG WEILIANG YUANSU KEXUE 18 12 1006-446X 2011 12-0001-28 1 2 2 1. 201800 2. 510070 R 244. 9 A 1 1. 1 3 2000 1. 1. 1 1973 3 52 299 31 136 100 32 1 13 2011-10 -20 1 2011 GUANGDONG WEILIANG YUANSU
More informationt H θ m [] Q Q q [] 9. 69kJ g q 32.0 620kJmol - 1 0. 500g mol C(s) 1 2 O (g) = CO(g) 2 SI n mol H 2H+H22H2+O2 [N2H41+O2g N2g+2H2O1] 1.2.3 qp qv [4] 1 C( ) O 2 (g) = CO(g), ( 2), 2 CO(g) CO (g),co(g) +
More information1... . 48 30 14 1000c.c 7.5 60 5 (7.5 ) (22 15 6 ). () 90 11 ~91 3 --- 1 2 3 4 () 91 4 ~91 5 --- 1 1 60 5 2 1 3 18 11 350ml ( ) 2 1 350ml 2 2 1-a 91 4 ~91 5 3 1-b 91 4 ~91 5 4 1-c 91 4 ~91 5 5 1 -- ab
More information一 学 校 基 本 情 况 目 录 二 部 门 预 算 报 表 ( 一 ) 收 支 总 表 ( 二 ) 收 入 总 表 ( 三 ) 支 出 总 表 ( 四 ) 财 政 拨 款 支 出 表 三 部 门 预 算 报 表 说 明 ( 一 ) 收 支 总 表 说 明 ( 二 ) 收 入 总 表 说 明 (
浙 江 大 学 2016 年 部 门 预 算 2016 年 5 月 1 一 学 校 基 本 情 况 目 录 二 部 门 预 算 报 表 ( 一 ) 收 支 总 表 ( 二 ) 收 入 总 表 ( 三 ) 支 出 总 表 ( 四 ) 财 政 拨 款 支 出 表 三 部 门 预 算 报 表 说 明 ( 一 ) 收 支 总 表 说 明 ( 二 ) 收 入 总 表 说 明 ( 三 ) 支 出 总 表 说 明
More information目 录 一 学 校 基 本 情 况 二 2016 年 预 算 报 表 ( 一 ) 中 南 大 学 收 支 预 算 总 表 ( 二 ) 中 南 大 学 收 入 预 算 表 ( 三 ) 中 南 大 学 支 出 预 算 表 ( 四 ) 中 南 大 学 财 政 拨 款 支 出 预 算 表 三 2016 年
中 南 大 学 2016 年 部 门 预 算 二 一 六 年 五 月 1 目 录 一 学 校 基 本 情 况 二 2016 年 预 算 报 表 ( 一 ) 中 南 大 学 收 支 预 算 总 表 ( 二 ) 中 南 大 学 收 入 预 算 表 ( 三 ) 中 南 大 学 支 出 预 算 表 ( 四 ) 中 南 大 学 财 政 拨 款 支 出 预 算 表 三 2016 年 预 算 情 况 说 明 (
More information信息参考
内 部 资 料 注 意 保 密 信 息 参 考 2016 年 第 1 期 ( 总 第 26 期 ) 党 政 办 公 室 编 2016 年 2 月 29 日 工 作 要 点 教 育 部 2016 年 工 作 要 点 (1) 中 共 北 京 市 委 教 育 工 作 委 员 会 北 京 市 教 育 委 员 会 北 京 市 人 民 政 府 教 育 督 导 室 2015 年 工 作 要 点 (10) 中 共
More informationMicrosoft Word - 15dbtb007
第 7 期 中 共 浙 江 大 学 委 员 会 办 公 室 2015 年 12 月 16 日 按 :2015 年 12 月 15 日, 学 校 召 开 了 2015 年 党 建 工 作 会 议, 党 委 书 记 金 德 水 同 志 作 出 重 要 讲 话, 深 刻 分 析 了 学 校 改 革 发 展 面 临 的 形 势, 对 加 强 和 改 进 学 校 党 的 建 设 进 行 了 部 署, 对 充
More informationSyngene GBOXHR Retsch MM400 KQ DE Eppendorf Table 1 The sources of Astragali Radix and Hedysarum Radix No. 1 AMM2011_NMGTY Astr
PCR 龙平, 崔占虎, 李虔全, 徐建平, 张春红, 周立社 * *, 李旻辉 ( 包头医学院, 内蒙古包头 014060) DNA 30 28 DNA trnl-trnf PCR PCR 136 bp 323 bp 10% PCR PCR Astragalus membranaceus Fisch. Bge. var. mongho- licus Bge. Hsiao A. membranaceus
More information